Sunday, March 30, 2014

5 Best Forestry Stocks To Invest In Right Now

Many frontier markets continue to stand out as particularly attractive to us right now, as a number of developed and even some established emerging markets have been experiencing a few soft GDP growth trends this year. Frontier markets are considered a subset of emerging markets, often smaller and less-developed. My travels recently took me to one of the largest frontier markets, Nigeria, where my team and I were able to see the changes taking place in the country and talk to company owners and managers about the challenges of doing business there. As we scouted for potential investment opportunities, we found some surprises too.

Nigeria boasts one of the fastest-growing economies in the world, with GDP growth rates above 6% every year since 20031. Home to more than 170 million people, it is the most populous country in Africa and the seventh most populated country in the world. The United Nations has projected its population could rise into the top three by 2050, potentially overtaking the United States2.

5 Best Forestry Stocks To Invest In Right Now: Altec Holdings SA (AXY)

Altec Holdings SA the parent company of Altec Group, is a Greece-based company engaged in the information technology and telecommunications fields. The Company's range of activities includes the manufacture, import, export, trade, distribution, leasing and support of computers and telecommunication materials, as well as the design, production, development, import, export, leasing and trading of software for computers and electronic cash registers. Its hardware products include a range of personal computers, servers and related equipment. Its software products include systems for enterprise resource planning, customer relationship management, accounting, human resource management, payroll and data warehousing, insurance brokerage software and equipment for call centers. It operates a retail network under the brand Microland. The Company has established subsidiaries in Romania, Bulgaria and Cyprus. Advisors' Opinion:
  • [By John Udovich]

    Yesterday, small cap geothermal stock U.S. Geothermal Inc (NYSEMKT: HTM) produced a geyser of a return when it surged 26.79%, meaning its worth taking a closer look at the stock verses the performance of other geothermal stocks like small cap Ormat Technologies, Inc (NYSE: ORA) and mid cap Calpine Corporation (NYSE: CPN).�First of all, I should mention there are some other geothermal stocks out there like Alterra Power Corp (CVE: AXY) and Ram Power Corp (TSE: RPG) who have their primary listing on Canadian exchanges with secondary ones on the OTC���meaning they may not be a good deal for American investors or easy to invest in. Second, U.S. Geothermal Inc itself is a good geothermal proxy as its�focused on developing, owning, and operating clean, sustainable electric power from geothermal energy resources and its�operating geothermal power projects at Neal Hot Springs, Oregon; San Emidio, Nevada; and Raft River, Idaho plus El Ceibillo, an advanced stage, geothermal prospect located within a 24,710 acre energy rights concession area near Guatemala City, the largest city in Central America.

5 Best Forestry Stocks To Invest In Right Now: Western Digital Corp (WDC)

Western Digital Corporation (WD) is a provider of solutions for the collection, storage, management, protection and use of digital content, including audio and video. Its principal products are hard drives, which are devices that use one or more rotating magnetic disks (magnetic media) to store and allow access to data. Its hard drives are used in desktop and notebook computers, corporate and cloud computing data centers, home entertainment equipment and stand-alone consumer storage devices. In addition to hard drives, its other products include solid-state drives and home entertainment and networking products. The Company operates as the parent company of its hard drive business, Western Digital Technologies, Inc. Effective March 8, 2012, the Company acquired Viviti Technologies Ltd. In May 2012, the Company completed the divestiture of certain 3.5-inch hard drive assets to Toshiba Corporation. As part of its deal with Toshiba, WD also completed its purchase of Toshiba Storage Device (Thailand) Company Limited (TSDT), which manufactured hard drives.

The Company offers a line of storage devices. Its hard drives include 3.5-inch and 2.5-inch form factors, capacities ranging from 80 gigabytes to three terabytes, nominal rotation speeds up to 10,000 revolutions per minute, and interfaces, such as Serial Advanced Technology Attachment (SATA) and Serial Attached SCSI (Small Computer System Interface) (SAS). In addition, the Company offers a family of hard drives specifically designed to consume less power than standard drives, utilizing its WD GreenPower Technology. Its solid-state drives include 2.5-inch and Compact Flash form factors, capacities ranging from 1 gigabyte to 256 gigabytes, and interfaces, such as SATA and PATA.

Client Compute Storage Products

Client compute consists of hard drives and solid-state drives for desktop and mobile personal computers (PC��). During the fiscal year ended July 1, 2011 (fiscal 2011), it shipped 151 million hard drive clie! nt compute unit. Its client compute storage products include WD Caviar, WD Scorpio and WD Silicon Edge. WD Caviar family of hard drives is designed for use in desktop PCs. WD Scorpio family of hard drives is designed for use in mobile PCs. WD Silicon Edge family of solid-state drives is designed for both read-intensive client/consumer applications and write-intensive original equipment manufacturer (OEM) applications.

Client Non-Compute Storage Products

Client non-compute consists of branded products and consumer electronics products. Its hard drive client non-compute unit shipments were 46 million, during fiscal 2011.

Branded Products

Branded products consists of hard drives embedded into WD-branded external storage appliances with capacities ranging from 250 gigabytes to 8 terabytes and using interfaces, such as Universal Serial Bus (USB) 2.0, USB 3.0, external SATA, FireWire and Ethernet network connections. Certain branded products models include software that assists customers with back up, remote access and management of digital content. Branded products also include its home entertainment and networking products. Its branded products include My Book and WD Elements Desktop family of storage appliances. My Passport and WD Elements Portable family of storage appliances include WD ShareSpace, WD TV and WD Livewire.

My Book and WD Elements Desktop family of storage appliances are designed to add external capacity to desktops and digital video recorders (DVRs), allow for the transfer and storage of videos directly from certain camcorders, and connect to networks to simplify storage for consumers. My Passport and WD Elements Portable family of storage appliances are designed for external portability weighing less than one-half of a pound and allow for the transfer and storage of videos directly from certain camcorders. WD ShareSpace is a network-attached storage system designed for home office or small office applications. WD TV m! edia play! ers connect to a user�� television or home theater system and play digital movies, music and photos from an integrated hard drive, network hard drives, any of its WD-branded external hard drives, other USB mass storage devices or content services accessed over the Internet. WD Livewire, which enables consumers to use their existing electrical outlets to extend Internet connections throughout the home.

Consumer Electronics Products

WD AV family of hard drives is designed for use in products, such as DVRs and audio and video applications. WD AV drives deliver the characteristics CE manufacturers.

Enterprise Storage Products

Enterprise consists of hard drives for traditional enterprise and nearline storage applications, as well as solid-state drives for embedded applications. Its hard drive enterprise unit shipments were 10 million, for fiscal 2011. Its enterprise storage products include WD S25 hard drive, WD VelociRaptor, WD RE and WD SiliconDrive. WD S25 hard drive is designed for mission-critical enterprise server and storage applications, such as data centers and data arrays. WD VelociRaptor hard drive is designed for enterprise server and storage applications. This hard drive is also used in the high-end desktop PC market for applications including gaming, servers and advanced computer-aided design/computer-aided manufacturing (CAD/CAM) systems. WD RE family of hard drives is designed for nearline storage enterprise applications. WD SiliconDrive family of solid-state drives features fast read/write speeds in high capacities and is designed for embedded system OEM applications.

The Company competes with Hitachi Global Storage Technologies, Intel Corporation, Micron Technology, Inc., Samsung Electronics Co. Ltd., Seagate Technology, STEC, Inc. and Toshiba Corporation.

Advisors' Opinion:
  • [By Daniela Pylypczak]

    Western Digital (WDC) announced on Wednesday that its chief financial officer, Wolfgange Nickl, is resigning.

    Nickl’s resignation from WDC will be effective November 17, 2013, when he becomes the new CFO at ASML Holding N.V. in the Netherlands. Nickl has served as CFO at Western Digital since August of 2010; prior to that, he served in several other positions within WDC’s finance and operations divisions. Western Digital has stated that it is in the process of searching for a new CFO.

    Western Digital shares traded 1.15% higher during Wednesday’s session. Year-to-date, the stock is up 48.90%.

Hot Insurance Stocks For 2014: Perrigo Company PLC (PRGO)

Perrigo Company plc, incorporated on March 23, 1988, is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. The Company�� businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia, and distributes into dozens of other markets worldwide, including Canada, China and Latin America. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

The Company operates through several wholly owned subsidiaries. In the United States, its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., PBM Products, LLC, PBM Nutritionals, LLC, Paddock Laboratories, LLC, Perrigo Diabetes Care, LLC (formerly CanAm Care, LLC), Sergeant's Pet Care Products, Inc. and Fidopharm, Inc. Outside the United States, its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Galpharm Healthcare Ltd., Orion Laboratories Pty Ltd and Rosemont Pharmaceuticals Ltd.

Consumer Healthcare

Perrigo Consumer Healthcare (CHC) operation includes the Company's United States, United Kingdom and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Perrigo CHC supplies more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as w! ell as vitamins, dietary supplements and nutritional drinks. Perrigo offers a range of products, such advertised brand products as Tylenol, Advil or One-A-Day. Tylenol has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.

Perrigo Nutritionals

Perrigo is a manufacturer of nutrition products for the store brand market. Nutrition products include infant formula, pediatric nutritionals and vitamins, minerals, and supplements. Acquired by Perrigo, Perrigo Nutritionals, formerly PBM Products, LLC, had introduced private-label, or store-brand infant formulas to the United States. Perrigo Nutritionals is the supplier of store-brand infant formulas and nutrition products. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world. Its pediatric nutritionals business extends its offerings to children well beyond infancy. Its baby cereals, toddler foods, and pediatric nutritional drinks are available as store brands at various retail locations throughout the United States and the international community. Perrigo manufactures a range of vitamins, minerals, and supplements, in every major segment of the business. Marketed under the store brand labels of the retailers in the food, drug, mass-merchandise and wholesale club channels, it manufactures over 395 formulas of dietary supplements. Its brands include Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex.

Rx Pharmaceuticals

The Company�� Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the United States market. Manufacturing operations are based in the United States and Israel. Perrigo's portfolio focuses on complex, high-barrier ophthalmological, topical foam and or! al liquid! formulations. Its products include Acetylcysteine Injection 200 mg/mL (6g/30mL), Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS, ACTIDOSE with SORBITOL, ACTIDOSE-AQUA, ASPIRIN SUPPOSITORIES USP, Bacitracin Ophthalmic Ointment USP, Belladonna and Opium Suppositories C-II, BENZOIN COMPOUND TINCTURE USP, Benzoyl Peroxide 10% Acne Medication Wash, CLOBETASOL PROPIONATE LOTION 0.05% and Docusate Sodium.

Active Pharmaceutical Ingredients

Primarily through the Company�� Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. It manufactures API at facilities in Israel, India and China. Perrigo API specializes in tailor-made research and process development of APIs and Finished Dosage Forms (FDFs).

Life Sciences

Through the Company�� Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with pharmaceutical companies. Its Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements. Products in life sciences segment include TYSABRI and ELND005. TYSABRI (natalizumab) is indicated for treatment of: Multiple Sclerosis: as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy; Crohn�� Disease (CD): Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn�� disease with e! vidence o! f inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of tumor necrosis factor-δΌͺ.

Other

Perrigo's Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses. Other pharmaceutical and medical diagnostic products are imported to Israel through exclusive agreements with pharmaceutical and diagnostics companies. This business is divided into two departments: Pharma-Israel and Tayco Diagnostics. Pharma-Israel operates in the Israeli market as a partner in the marketing, sales and distribution of Rx (dermatology, gastroenterology, blood products, CNS, urology and other fields), OTC, generics, branded generics, dermo-cosmetics and dietary supplements. Tayco, the diagnostics division of Perrigo-Israel Pharmaceuticals Ltd., specializes in marketing and sales of medical laboratory systems, reagents, accessories and consumables. It also markets self-monitoring medical devices for diagnosis and treatment of diabetes. The division operates throughout Israel to service the central laboratory, hospital, clinic, point of care and self-testing markets. Its activities in the medical and research fields in Israel cover all market segments: medical (private and public health services), research institutions and the biotech industry.

The Company competes with Dr. Reddy�� Laboratories, Ltd., Actavis Inc., Aaron Industries, Inc., Ohm Laboratories, Inc., PL Developments, LNK International, Inc., Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber), Danone Baby Nutrition, Bayer AG, Pfizer, Inc., Rexall Sundown, Inc., Apotex, Glenmark Generics Inc., Impax, Prasco, Sandoz, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, and Zydus Pharmaceuticals.

Advisors' Opinion:
  • [By Laura Brodbeck]

    Stocks moving in the pre-market included:

    Wyndham Worldwide Corp (NYSE: WYN) gained 2.65 percent in pre-market trade, adding to its 4.02 percent rise over the past five days. Goldman Sachs Group Inc (NYSE: GS) gained 1.42 percent in pre-market trade after falling 0.95 percent on Wednesday. Perrigo Co (NYSE: PRGO) gained 0.66 percent in pre-market trade after losing 1.96 percent in the past week. U.S. Bancorp (NYSE: USB) lost 0.61 percent in pre-market trade after gaining 0.80 percent over the past five days.

    Earnings

  • [By Holly LaFon]

    During the quarter, Perrigo (PRGO) announced strong September quarter adjusted earnings growth of 20%.� We say ��djusted��because the Company incurred what we believe are non-recurring charges related to the recent purchase of Elan Corporation, which is a branded-drug company domiciled in Ireland.� Upon the closing of this purchase, Perrigo has ��e-domiciled��itself in Ireland, with an effective tax rate meaningfully below what they were subjected to in the U.S.� Given that the Company actively pursues a strategy of inorganic growth as much as it pursues organic growth - having acquired six new businesses over the past 18 months (including Elan) - we expect that this new tax structure should make future acquisitions, particularly those U.S. based businesses, much more attractive.� Further, Perrigo�� core business, which includes private-label over-the-counter (OTC) pharmaceuticals and infant formula, drove much of the year-over-year growth.� The Company�� unrivaled scale in manufacturing and marketing of store-branded offerings continues to enable retailers to mimic the value proposition of OTC pharmaceuticals and infant formula.� This ��tore-brand conversion��is a multi-year trend that we expect will continue for the foreseeable future as consumers continue to become more value-conscious, yet more comfortable with store-brand quality that Perrigo helps engineer.�

  • [By Keith Speights]

    The company can't count on AndroGel to help too much. Perrigo (NYSE: PRGO  ) gained approval from the U.S. Food and Drug Administration in February for a generic version of a less concentrated form of the gel in February.

  • [By Ben Levisohn]

    While the Paladin deal expands potential growth areas for the company, Endo�� business development focus remains on the heavily fragmented US market, where the company believes it can create the most value by operating acquired assets more efficiently. Management sees a robust pipeline of potential future deals and does not necessarily view other companies that benefit from a low tax rate [(Actavis (ACT), Perrigo (PRGO), Valeant Pharmaceuticals International (VRX))] as direct competitors for the assets it is targeting. We believe business development is likely to accelerate post the Paladin deal and the re-domicile to Ireland, and view Endo as in the early stages of its consolidation strategy…And with greater than $2 billion in capacity to do deals, we expect business development to accelerate.

5 Best Forestry Stocks To Invest In Right Now: KS Bancorp Inc (KSBI)

KS Bancorp, Inc. serves as the holding company for KS Bank, Inc. (the Bank). The Bank is a community financial institution, which is locally owned and operated. The Bank offers a range of traditional deposit and loan products for consumers and businesses. The Bank offers a range of loans that include Personal Loans, Fixed Rate and Adjustable Rate Home Mortgage Loans, Consumer Loans, Reverse Mortgages, Home Construction Loans, Auto Loans, Boat Loans and Education Loans.

The Bank focuses on attracting retail deposits and using such deposits to make mortgage loans, construction loans, business loans, consumer loans and equity line loans. KS Bank conducts its operations through eight full service retail offices located in Johnston, Wake, Wilson, and Wayne counties in North Carolina.

Advisors' Opinion:
  • [By CRWE]

    Today, KSBI remains (0.00%) +0.000 at $7.50 thus far (ref. google finance 9:49AM EDT July 23, 2013).

    KS Bancorp, Inc. previously reported unaudited net income available to common shareholders of $200,000, or $.15 per diluted share, for the three months ended June 30, 2013, compared to a net income available to common shareholders of $86,000, or $.07 per diluted share, for the three months ended June 30, 2012. For the six months ended June 30, 2013, the Company reported net income available to common shareholders of $325,000, or $.25 per diluted share, compared to $314,000, or $.24 per diluted share, for the six months ended June 30, 2012

  • [By CRWE]

    Last Friday, KSBI previously surged (+6.67%) up +0.50 at $8.00 with 235 shares in play at the close (ref. google finance July 26, 2013 ��Close).

    KS Bancorp, Inc. previously reported unaudited net income available to common shareholders of $200,000, or $.15 per diluted share, for the three months ended June 30, 2013, compared to a net income available to common shareholders of $86,000, or $.07 per diluted share, for the three months ended June 30, 2012. For the six months ended June 30, 2013, the Company reported net income available to common shareholders of $325,000, or $.25 per diluted share, compared to $314,000, or $.24 per diluted share, for the six months ended June 30, 2012

5 Best Forestry Stocks To Invest In Right Now: Lions Gate Entertainment Corp (LGF)

Lions Gate Entertainment Corp. (Lionsgate), incorporated on April 28, 1997, is an entertainment company with a presence in motion picture production and distribution, television programming and syndication, home entertainment, family entertainment, digital distribution, new channel platforms and international distribution and sales. During fiscal year ended March 31, 2012 ( fiscal 2012), Lionsgate released 14 motion pictures theatrically, which included films developed and produced in-house, films co-developed and co-produced and films acquired from third parties. In December 2011, the Company formed a partnership with Saban Capital Group, Inc (SCG) and Celestial Pictures to create Celestial Tiger Entertainment Limited (Celestial Tiger Entertainment), a media company dedicated to entertaining audiences in Asia and beyond. In January 2012, the Company acquired 16 % interest in Celestial Tiger Entertainment. On January 13, 2012, the Company acquired Summit Entertainment, LLC (Summit), an independent global theatrical motion picture development, production, and distribution studio. In February 2012, Tele Munchen Group acquired rights to Charlie Sheen Sitcom ANGER MANAGEMENT for Germany, Austria and German speaking Switzerland from the Company�� international television division. Effective March 26, 2013, CBS Corp acquired 50% interest in The TV Guide Network from the Company. In June 2013, CBS Corp acquired TV Guide Digital, which includes the popular TVGuide.com and TV Guide Mobile properties from the Company.

The Company�� television business consists of the development, production, syndication and distribution of television productions. As of March 31, 2012, it produced and syndicated 19 television shows, which air on 14 networks and distribute over 200 series globally. It distributes its library of approximately 13,000 motion picture titles and television episodes and programs directly to retailers, rental kiosks, through various digital media platforms, and pay and free television c! hannels in the United States, the United Kingdom and Ireland, and indirectly to other international markets through its subsidiaries and various third parties. It also distributes product through Celestial Tiger Entertainment, its joint venture with SCG and Celestial Pictures, a company wholly owned by Celestial Pictures; Horror Entertainment, LLC (FEARnet), its joint venture with Sony Pictures Television Inc. (Sony) and Comcast Corporation (Comcast); Studio 3 Partners LLC (EPIX), its joint venture with Viacom Inc. (Viacom), its Paramount Pictures unit (Paramount Pictures) and Metro-Goldwyn-Mayer Studios Inc. (MGM), and TV Guide Network, TV Guide Network On Demand and TV Guide Online (www.tvguide.com) (collectively, TV Guide Network), its joint ventures with One Equity Partners (OEP), the global private equity investment arm of JPMorgan Chase & Co.

Production

The Company takes a disciplined approach to film production with the goal of producing content, which it can distribute to theatrical and ancillary markets, which include home entertainment, pay and free television, on-demand services and digital media platforms, both domestically and internationally. During fiscal 2012, it produced, participated in the production of, completed or substantially completed principal photography of motion pictures, which included Good Deeds, The Hunger Games, What To Expect When You're Expecting, Tyler Perry's Madea's Witness Protection, Step Up Revolution, The Possession, The Perks of Being A Wallflower, The Twilight Saga: Breaking Dawn - Part 2, The Last Stand, Warm Bodies, Now You See Me, Tyler Perry's The Marriage Counselor, Tyler Perry's We The Peoples and Nurse 3D.

The Company�� television business consists of the development, production, syndication and distribution of television programs. It licenses its television productions to the domestic cable, free and pay television markets, as well as through various digital platforms. During fiscal 2012, it produced 19 televi! sion show! s, aired original programming on 14 networks and distributed over 200 series globally. Domestic television programming includes one-hour and half-hour scripted and reality programming. During fiscal 2012, it produced the episodes of domestic television programming 13 episodes of the fifth season of the series Mad Men,; 13 episodes of the seventh season of Weeds, a half-hour comedy for Showtime; 10 episodes of the fourth season of Nurse Jackie, a half-hour comedy for Showtime; 13 episodes of the third season of Blue Mountain State, a half-hour comedy for Spike TV; and eight episodes of the first season of Boss, a one-hour drama for Starz.

The Company is engaged in the development, acquisition, production and distribution of animation projects for full theatrical release, television and digital versatile disk (DVD) release. Its direct-to-video animated movies with Marvel include Ultimate Avengers, Ultimate Avengers 2, The Invincible Iron Man, Doctor Strange, Next Avengers: Heroes of Tomorrow, Hulk vs. Thor/ Wolverine, Planet Hulk and Thor, Tales of Asgard. Its music department oversees music for its theatrical and television slates, as well as the music needs of other areas within its company. Its publishing revenue derives from performance royalties generated by the theatrical exhibition of its films and the television broadcast of its productions. Music released for its theatrical slate includes overseeing songs, scores and soundtracks for all of its productions, co-productions and acquisitions. During fiscal 2012, through its label partner Universal Republic, it released the soundtrack The Hunger Games Songs from District 12 and Beyond. In addition, it released through Universal Republic the score album, The Hunger Games: Music from the Motion Picture, by composer James Newton Howard. During fiscal 2012, it released Music Videos And Performances From The Twilight Saga Soundtracks: Volume 1, a collection of music videos and live performances from bands featured on the soundtracks from the ! first thr! ee Twilight films. In November 2011, it also released the first single from The Twilight Saga, Breaking Dawn - Part 1, It Will Rain, by Bruno Mars. During fiscal 2012, it also released soundtracks to One For The Money (Lakeshore Records), Abduction (Epic Records), Warrior (Lakeshore Records), Conan The Barbarian 3D (Warner Brothers Records) and The Devil's Double (Lakeshore Records).

Music released for the Company�� television slate includes overseeing songs, scores and soundtracks for all of its television productions. During fiscal 2012, it released Zou Bisou Bisou, a vinyl single and accompanying digital download derived from Jessica Pare's (Megan Draper) on-screen performance in the first episode of season 5 of Mad Men. In addition, in collaboration with FEARnet.com, it released an original soundtrack forFriday the 13th and for Boss, which featured a collaboration of Satan Your Kingdom Must Come Down between Robert Plant and Bosscomposer Brian Reitzell, yielding the show's evocative main title theme.

Distribution

The Company distributes motion pictures directly to the United States movie theaters. It constructs release schedules taking into account moviegoer attendance patterns and competition from other studios' scheduled theatrical releases. During fiscal 2012, Lionsgate released 14 motion pictures theatrically, which included films developed and produced in-house, films co-developed and co-produced and films acquired from third parties. During fiscal 2012, Summit released eight motion pictures theatrically, which included films developed and produced in-house, films co-developed and co-produced and films acquired from third parties. Its wholly owned subsidiary, Mandate Pictures LLC (Mandate Pictures), is a full-service production and financing company.

During fiscal 2012, Mandate Pictures' financed and produced pictures released included 50/50, A Very Harold & Kumar 3D Christmas and Young Adult. 50/50 was released by Summit in September 2011! . Young A! dult is written by Diablo Cody and released by Paramount Pictures in December 2011. A Very Harold & Kumar 3D Christmas was released by Warner Bros. Pictures in November 2011. During fiscal 2012, Mandate Pictures also financed and produced the Untitled Diablo Cody project starring Julianne Hough, Russell Brand, Octavia Spencer and Holly Hunter. As of March 31, 2011, Mandate Pictures' production and development slate included a comedy written and directed by Seth Rogen and Evan Goldberg (working title End Of The World). Mandate Pictures also maintains a partnership with Ghost House Pictures as a production label dedicated to the financing, development and production of films in the horror/thriller genre. Under this partnership, Mandate Pictures has produced 30 Days of Night: Dark Days, Drag Me To Hell, 30 Days of Night, The Grudge I and II, The Messengers and Boogeyman.

The primary components of the Company�� international business are, on a territory by territory basis through third parties or directly through its international divisions: the licensing and sale of rights in all media of its in-house product; the licensing and sale of third party product on an agency basis; the licensing of rights in all media of the in-house Summit product on an output basis; the licensing and sale of in-house catalog product or libraries of acquired titles (such as those of Miramax, Artisan Entertainment and Modern Times Group), and direct distribution. The Company sells or licenses rights in all media on a territory by territory basis (other than the territories where Lionsgate and/or Summit self-distribute) of its in-house Lionsgate and Summit product, as well as titles from Mandate Pictures and Ghost House Pictures; its catalog product or libraries of acquired titles, and product produced by third parties, such as Alcon Entertainment, Vendome Pictures, River Road Entertainment, CBS Films, Relativity Media and other independent producers.

During fiscal 2012, the Company�� output deals f! or Summit! product covered nine territories, including new output deals for Australia/New Zealand, Spain, the Commonwealth of Independent States and Eastern Europe, as well as output deals in Canada, France, Germany/Austria, Scandinavia, and the United Kingdom. It generates revenue through a sales agency business for third party product. Films sold by it include such in-house productions as What to Expect When You're Expecting, Hope Springs and Now You See Me. Third party films sold by includes Beautiful Creatures and The Railway Man. During fiscal 2012, its sales had record-breaking international box office results with releases, including The Twilight Saga: Breaking Dawn - Part 1, Immortals, and The Hunger Games.

The Company self-distributes motion pictures (excluding Summit releases) in the United Kingdom and Ireland through its subsidiary, Lions Gate UK Limited (Lionsgate UK). During fiscal 2012, Lionsgate UK's theatrical slate included such titles, such as Warrior, Abduction, 50/50, Ralph Fiennes' British Academy of Film and Television Arts Nominated directorial debut, Coriolanus, David Cronenberg's A Dangerous Method, and The Hunger Games. In May 2011, Lionsgate UK announced that it was co-financing and co-producing a new contemporary sci-fi adventure project The Fallen, and in November 2011, the production of Keith Lemon: The Film, a comedy with Celebrity Juice's host and international ladies' man Keith Lemon. In November 2011, Lionsgate UK also announced a multi-year partnership with Icon Film Distribution for release of theatrical titles moving forward.

Home entertainment distribution includes distribution of product to the home entertainment market, including home video, DVD, Blu-ray, video-on-demand (VOD) and digital/electronic distribution. During fiscal 2011 calendar year, Blu-ray represented 19% of new released packaged media revenue from its theatrical releases. It distributes or sells its titles directly to merchandisers, such as Wal-Mart, K-Mart, Best Buy, Target and Cos! tco, and ! others who buy its DVDs and Blu-ray discs to sell directly to consumers. During 2012, sales to Wal-Mart accounted for approximately 38% of net home entertainment packaged media revenue. It also directly distributes its titles to the rental market through Netflix, Redbox, Blockbuster and Rentrak. In addition to its theatrical releases each year, it also acquires and distributes approximately 70 titles annually that have commercial potential in video and ancillary markets, and approximately 50 digital only titles. It also distributes television product on video, including seasons one through five of Mad Men, seasons one through eight of Weeds, seasons one through four of Nurse Jackie, the first season of Boss, certain Saturday Night Live product in its library, seasons one through three of Blue Mountain State, the entire catalog of the comedy series Moonlighting, the entire catalog of the comedy series Will and Grace, the entire catalog of Little House on the Prairie and certain Disney-ABC Domestic Television series. During fiscal 2012, it also released several direct-to-video titles, including two Tyler Perry titles, Tyler Perry's Laugh to Keep from Crying and A Madea Christmas: The Play, and Set Up. Its fitness lineup includes series, such as Denise Austin, Jillian Michaels, The Biggest Loser and Dancing With The Stars, as well as titles from Billy Blanks Jr., and Jane Fonda. During fiscal 2012, it released on DVD the theatrical release of Madea's Big Happy Family, as well as the direct-to-video releases Tyler Perry's Laugh to Keep from Crying and A Madea Christmas: The Play. Its domestic family entertainment division is a distributor of children's product.

The Company syndicates television programming through its subsidiary, Debmar-Mercury. In fiscal 2012, Debmar-Mercury distributed approximately 1,100 hours and produced approximately 550 episodes of television programming. In fiscal 2013, Debmar-Mercury intends to distribute approximately 1,200 hours and produce approximately 550 episode! s of tele! vision programming. Debmar-Mercury produces and distributes The Wendy Williams Show, distributes the ITV Studios America produced The Jeremy Kyle Show, distributes Tyler Perry's House of Payne and its spinoff, Meet the Browns, and Revolution Studios' produced Are We There Yet, which will air simultaneously in broadcast syndication and on TBS starting in the fall of 2012. Debmar-Mercury also distributes the strips Hell's Kitchen, South Park, True Hollywood Story and Family Feud, which has had first run syndication and has been sold to various television stations through the fall of 2015. Debmar-Mercury continues to distribute a movie library featuring Lionsgate titles, as well as those from Revolution Studios. In July 2011, Debmar-Mercury announced that the first eight seasons of Hell's Kitchen, produced by ITV Studios America, will be exclusively available on the Hulu Plus subscription service beginning immediately, while current episodes from season nine and a rotating selection of library episodes will also be available on the free, ad-supported Hulu service. In April 2011, Debmar-Mercury announced that TBS ordered ten episodes of the new series Tyler Perry's For Better or Worse, a sitcom based on Tyler Perry's hit film Why Did I Get Married?. The series launched in November 2011. In February 2012, Debmar-Mercury received an order from TBS for an additional 35 episodes of the new series. Overall, 439 episodes of Debmar-Mercury's syndicated sitcoms with Tyler Perry have been ordered to-date.

In July 2011, the Company announced that FX had ordered Charlie Sheen's Anger Management. It has more than 1,000 titles in active distribution in the domestic cable, free and pay television markets. Pay television rights include rights granted to cable, direct broadcast satellite and other services paid for by subscribers. It sells its library titles and new product to major cable channels, such as pay networks, including EPIX, HBO, Starz and Showtime, as well as basic cable channels, including USA Net! work, FX,! Turner Networks, BET, ABC Family, SyFy, Lifetime, MTV, Comedy Central, Spike, AMC Networks, OWN, Reelz, Telemundo and Telefutura. It also directly distributes pay-per-view and VOD to cable, satellite and Internet providers, such as Comcast, Time Warner, Cox Communications, through iN Demand, Charter Communications, AT&T Uverse and Verizon FIOS through Avail-TVN, Cablevision, DirecTV and DISH Network. During fiscal 2012, it completed multi-year licensing agreements with Starz (for greater than 500 titles) and Showtime (for greater than 250 titles). In addition, it continues to distribute its library of motion picture titles and television episodes and programs through EPIX, its joint venture with Viacom, Paramount Pictures and MGM.

The Company delivers content through a range of digital media platforms. It distributes first run theatrical films, television series, its movie library, third party product and product not available on DVD to distribution outlets, including iTunes, Amazon, Microsoft's Xbox, Sony's Playstation Network, Netflix, Best Buy/CinemaNow, Hulu, YouTube, and Wal-Mart/Vudu. Through its partnership with EPIX, it offers product through the Internet and to multiple devices for consumption anytime/anywhere by EPIX subscribers. EPIX has subscription pay television rights to new releases and movies from the libraries of its partners and makes these movies available to Netflix 90 days after their premium pay television and subscription on demand debuts. In addition, its licensing relationship with Netflix continues. In April 2011, it announced a multiyear syndication deal with Netflix pursuant to which it licensed the first four seasons of Mad Men to be watched instantly by Netflix members beginning July 2011, with additional seasons being added annually after they air on their respective seasons on the AMC network.

The Company operates FEARnet, a branded multiplatform programming and content service provider of horror genre films, in connection with partners Comca! st and So! ny, and owns an interest in Break Media, a viral marketing company that creates new opportunities for showcasing the feature films and television programming. In addition, it has partnered with YouTube to create branded Lionsgate channels, which enable the Company to post full length films and television episodes and to post promotional scenes from its film and television libraries. In addition to sharing advertising revenue from the channel, a banner on the page leads to its online shop, where the films and shows highlighted in the promotional scenes are available for purchase as DVDs or Blu-ray discs in digital form.

Advisors' Opinion:
  • [By Rick Munarriz]

    In the following video, Motley Fool analyst Rick Munarriz fields a question from�a Fool reader curious about where to stand on�Lions Gate� (NYSE: LGF  ) and other entertainment companies, asking: "Which entertainment stock should I buy? Am I too late with buying Lions Gate? If so, what other company should I buy now?"

  • [By Jon Friedman]

    At this time of year, the public is fixated with the summer movie blockbusters. Meanwhile, the studio stocks are up 47 percent as sentiment builds for the summer lineup and the sector advances toward its seasonal high point. Lions Gate Entertainment� (NYSE: LGF  ) �trades currently at about 13.9 times the consensus EBITDA (earnings before interest, taxes, depreciation and amortization) to the group's average of 13.2 times, which is below the historical premium and group average, Wible notes in his report. At the same time, DreamWorks Animation (NASDAQ: DWA  ) "looks rich at 19.3 EBITDA, which is higher than its 4% premium."

Are Stocks About to Get Crushed?

Earnings season is upon us, and many analysts are predicting that it won't be pretty. According to data analysis company FactSet Research Systems, earnings at S&P 500 companies are expected to contract by 0.6% (link opens PDF), marking the second year-over-year decline in three quarters.

Aluminum-maker Alcoa (NYSE: AA  ) kicks things off after the bell today. Figures available on Yahoo! Finance show that analysts expect Alcoa to report between $0.04 and $0.13 per share in earnings, with a consensus estimate of $0.08 per share.

But while the purported economic bellwether is the first company on the Dow Jones Industrial Average (DJINDICES: ^DJI  ) to report, does its performance set the tone for the rest of earnings season? FactSet's John Butters suggests that it just may be: "Recent history shows that when Alcoa has beat estimates, the price of the index has increased about 80% of the time over the next three months." Yet, as Butters goes on to explain, "When Alcoa has missed estimates, the price of the index has actually increased nearly as often as it has decreased over the next three months."

In other words, perhaps there isn't such a strong causal relationship after all.

The bigger issue is how the banks performed over the first three months of the year. "Most of the people I'm talking to have low expectations for earnings," an executive told The Wall Street Journal. "There's a lot of trepidation over what the banks will report."

The nation's first- and fourth-largest banks by assets, JPMorgan Chase and Wells Fargo, get the ball rolling this Friday. As I discussed, analysts will be watching three things in particular: mortgage originations, expenses, and trading profits or losses in the wake of the Cyprus bailout.

To be fair, if the performance of the market today is any indication, investors don't seem to be overly concerned, as the Dow is up a negligible four points with an hour left in trading.

Today's sluggish market could, however, have more to do with an impending speech by Federal Reserve Chairman Ben Bernanke scheduled for later today. Bernanke is expected to reaffirm the central bank's support for its current monetary policy, under which it's buying $85 billion in Treasuries and agency mortgage-backed securities per month in order to boost housing demand and compress long-term interest rates.

So will stocks get crushed this earnings season? It remains to be seen. On the one hand, earnings could well be lackluster, led in particular by the banks. But on the other, the Fed is doing everything it can to pick up the slack.

Is now a good time to buy Alcoa stock?
Materials industries are traditionally known for their high barriers to entry, and the aluminum industry is no exception. Controlling about 15% of global production in this highly consolidated industry, Alcoa is in prime position to take advantage of growth that some expect will lead to total industry revenue approaching $160 billion by 2017. Based on this prospect and several other company-specific factors, Alcoa is certainly worth a closer look. For a Foolish investment perspective on this global giant, simply click here now to get started.

Friday, March 28, 2014

Retiring Abroad: Saving Money, Finding Adventure

Advisors typically seek to improve their clients’ financial well-being by increasing their wealth, but a less common approach that can potentially have as big an impact is to reduce their expenses.

In the college finance realm, for example, a few elite advisors are doing more than helping their clients fund 529 college savings accounts; they are also poring over financial aid differences among colleges that can cut tuition by $5,000 a year. That’s $20,000 over four years multiplied by the number of children the parent is supporting.

Now imagine saving your client not tens of thousands of dollars, but hundreds of thousands of dollars — not by choosing a lower-cost college but rather by helping them choose a more affordable country in which to retire.

That is now possible as the international retirement trend gathers steam, and indeed authors Suzan Haskins and Dan Prescher, in their newly released book "The International Living Guide to Retiring Overseas on a Budget," affirm it is possible to live quite comfortably on just $25,000 a year.

“If you can get better weather, great health care, enjoy a different culture and immediately cut your cost of living in half, that’s like an arbitrage play. Your standard of living more than doubles overnight,” says Prescher, who with Haskins, his wife, spoke with ThinkAdvisor from their home in Cotacachi, Ecuador.

The Omaha transplants don’t miss Nebraska’s freezing winters or brutally hot summers, which used to generate $500-a-month utility bills. Today their utilities run about $30 a month, including water.

Property taxes on their 1,100 square foot condo total just “52 and change” a year. Gasoline costs less than $1.50 a gallon, but because public transportation is “ridiculously cheap” and taxis and buses “ubiquitous,” the couple doesn’t own a car, saving further on insurance and maintenance.

“We actually walk everywhere [amid] cobblestone streets and Spanish colonial architecture,” Haskins says, but they shell out the $2 it costs to take a two-hour ride to the Ecuadorian capital, Quito, when they want to attend the symphony, view an art exhibit or visit a specialist doctor.

“We’ve never paid more than $10 for a taxi, and that was to go to the provincial capital,” a 30-minute ride away, Prescher says.

The couple work as writers for International Living magazine, and just interviewed a couple aged 68 paying just $350 a month for health care in Mexico. Their insurance policy, they say, has far better coverage than their policy in the U.S., where they were paying $1,200 a month 10 years ago — coverage they estimate might be $2,000 today.

But beyond professional experience interviewing expats and their current living situation, Prescher and Haskins draw on more than 12 years of experience living in two places in Ecuador (Quito as well as Cotacachi); three in Mexico (Lake Chapala, San Miguel de Allende; and Merida); and half a year each in Panama City, Panama, and San Juan del Sur, Nicaragua — and have therefore charted a path for others.

“It used to be a pretty exotic idea, but in the last five or 10 years, with the internet, it’s a mainstream idea now,” says Prescher. “Not everybody will do it; it’s for people with a sense of adventure, people with a tolerance for novelty … You have to be willing to leave your comfort zone.”

But going outside your comfort zone need not be quite so uncomfortable.

“Most people retiring are of a certain age and want things to be easier,” says Haskins. “There are places in Mexico or Costa Rica that are just a short flight back to home.” She adds that options even include English-language destinations (Belize) or places that use the U.S. dollar as currency (Panama, Ecuador).

“We suggest you ruthlessly profile yourselves,” Prescher says.

For those attracted to the benefits of international living — its lower cost and adventure — the self-profiling should include an awareness of potential difficulties.

“If you can’t tolerate waiting in line; if you don’t like noise; if you get nervous trying to communicate in another language and wonder why they don’t speak English, it might not be right for you,” Prescher says.

“Your neighbors might have chickens or cows; roosters sometimes crow at 2 or 3 a.m.; wedding parties with loud bands can last for three days. I don’t even hear it anymore,” Haskins adds. “None of these problems are insurmountable.”

Initially at least, it is the separation anxiety that presents the biggest hurdle. But modern technology can help. Skype, which allows the two authors to stay in regular contact with their new grandchild in the States, is one way to lessen the potential pain of separation.

Patience is also required. “Things just don’t happen as quickly or conveniently as in the States,” Prescher says. But there’s a positive flip side, says Haskins:

“The rest of world is more polite. We’re very informal. We forget to say: ‘how are you? how’s your family?’”

If a potential retiree has decided they are up for it, Haskins and Prescher endeavor to help readers determine where to live, and indeed their book’s middle section looks at countries and, more narrowly, communities that might make sense.

The focus in not exclusively Latin America, though they think our southern neighbors have the most advantages for Americans who still have close attachments, as well as “birthday parties and funerals” to attend.

For example, they cite Malaysia and Thailand as the top two destinations in Asia (with Cambodia up and coming), with Malaysia being especially attractive for those who seeking plentiful access to English speakers.

In Europe, they focus, as Haskins puts it, “on areas that are more suitable because of better weather, lower costs and health care” advantages, such as the Limousin region of France, Spain’s Costa del Sol and southern Italy.

“If money is no object you might as well settle in Paris or Rome,” says Prescher, but since their book is written for those for whom money is an object, they focus on “places that are convenient, have good infrastructure and an excellent quality of life,” he adds.

The final segment of their book involves what to do when you get to your selected community, based on the supposition that retirees no longer lie on hammocks.

One thing to expect is that expats tend to find each other:

“You tend to rely on each other,” Haskins says, noting expats tend to ask each other for advice, “but we like to try to meet our Ecuadorian neighbors as well — because that’s part of the experience, immersing yourself in the culture.”

Expats also like to share their ‘horror’ stories about things that Americans take for granted.

“You can’t get things done in Latin America in a phone call,” Prescher says. “You make an appointment. If you’re a Type-A American, you’re not going to be happy.”

But if you don’t fall into that category, Haskins notes the extremely pleasant aspects of daily life, for example the fresh produce, which costs just pennies. “You not only reduce your cost of living but you’ll be healthier, too,” she says.

The couple’s values have evolved as a result. Noting that U.S. “consumerism slaps you in the face” on visits home, they’ve grown to appreciate the simplicity of life abroad, and as “serial relocators” have come to acquire fewer and fewer possesions.

And with inevitable slip-ups like asking the bartender for “dos besos” (two kisses) instead of “dos vasos” (two glasses), the authors say having a sense of humor is one more requirement of retiring abroad.

Wednesday, March 26, 2014

Vanguard Natural Resources Remains a Strong Income Play

Several weeks ago, I wrote an article that suggested that Vanguard Natural Resources (NASDAQ: VNR  ) could offer a way to hedge the costs of heating your home this past winter given the exceptionally cold weather and high bills. Well, now the winter is beginning to wind down (the snow that some of us saw this past winter not withstanding), and soon it will be spring with its accompanying lower heating bills. So, should anyone who bought Vanguard as protection against high heating bills sell their shares now? There is little reason to, as the company still offers a very strong monthly dividend and reported very strong results at the end of last month.

Very strong results
Vanguard Natural Resources reported its fourth-quarter and full-year 2013 results on February 26, 2014. The tag line to the company's earnings announcement states that Vanguard achieved record adjusted EBITDA, production and proved reserves in 2013. This was indeed the case. Vanguard had an adjusted EBITDA of $74.3 million in the fourth quarter, an increase of 11.7% over the fourth quarter of last year.

In addition, Vanguard had an adjusted EBITDA of $309.7 million in 2013, an increase of 34.4% over 2012's result. Vanguard also achieved vastly higher production in 2013 than in 2012. The company averaged 35,448 barrels of oil equivalent per day in 2013 compared to 18,298 barrels of oil equivalent per day in 2012.

Strong forward growth prospects
Towards the end of 2013, Vanguard announced that it is spending $581 million to acquire a stake in two of the most prolific natural gas fields in the United States. These two fields are the Pinedale Anticline and Jonah fields located in southwestern Wyoming. The fields currently contain 2,000 producing wells between them, but Ultra Petroleum (NYSE: UPL  ) and QEP Resources (NYSE: QEP  ) , the operators for the fields and Vanguard's partners in the development of these fields, plan to drill another 970 wells, which will obviously substantially increase Vanguard's production from the fields going forward.

Vanguard itself will embark on a development program in these fields once the deal to acquire them is completed. The company plans an eight-rig drilling program in 2014 with the goal of drilling two wells per month. All in all, the acquisition of these properties is expected to increase Vanguard's proved reserves by 80% and the company's average daily production by 55%. Both of these things are very good news for Vanguard Natural Resources and its unitholders. The increase in production is especially good for income-focused investors as the increased production is likely to boost Vanguard's distributable cash flow, which means that Vanguard's unitholders may begin seeing higher monthly distributions.

Vanguard predicts greatly rising output
Vanguard provided its forward-looking production guidance as a part of its earnings results and, as I outlined above, Vanguard expects its production to increase significantly. In 2013, Vanguard produced 8,462 barrels of oil per day on average. The company expects to increase this to 8,800 to 9,400 barrels of oil per day on average in 2014.

This is certainly a respectable increase but it is nothing compared to the increase that the company expects to see in its natural gas production. In 2013, Vanguard Natural Resources averaged 137,632 Mcf/day of natural gas production and 4,047 barrels per day of natural gas liquids production. In 2014, Vanguard Natural Resources expects to produce an average of 215,000-229,000 Mcf of natural gas per day and 7,200-7,650 barrels of natural gas liquids per day. Clearly, this is a very substantial increase that should prove greatly accretive to revenue and cash flow so long as natural gas prices remain somewhat steady.

Maintaining a high distribution yield
Vanguard maintains a very high yield that should appeal to income-focused investors. On March 17, Vanguard announce  that it intends to pay a cash distribution of $0.21 per unit in the month of April. As Vanguard pays its distributions monthly, this corresponds to an annualized distribution of $2.52 and a distribution yield of 8.4% at the company's current unit price. This yield could make Vanguard quite appealing even in the absence of growth, but the fact that Vanguard is likely to see forward growth could make the company a very appealing play.

9 rock-solid dividend stocks you can buy today
One of the dirty secrets that few finance professionals will openly admit is the fact that dividend stocks as a group handily outperform their non-dividend paying brethren. The reasons for this are too numerous to list here, but you can rest assured that it's true. However, knowing this is only half the battle. The other half is identifying which dividend stocks in particular are the best. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.

 

Canadian Tech Trio

Many investors think of Canada as the land of mining stocks; yet the nation is also home to thousands of companies in computing, e-commerce, and IT, notes Michael Robinson. In Money Morning, the analyst looks at a trio of Canadian tech opportunities.

Mitel Networks (MITL)

Small-cap Mitel is known for its advanced contact center platform that includes mobile chat and also helps mid-market firms generate sales leads while lowering expenses.

In late January, Mitel completed the $370 million merger with fellow Canadian tech firm, Aastra Technologies. The move solidifies its position in cloud-computing and gives Mitel an annual sales rate of around $1.1 billion.

It also means the combined firm now has 60 million users around the world and makes Mitel the market leader in Western Europe.

The new momentum means CEO Richard McBee's growth strategy is working. The stock is up more than 161% in the last 12 months. But don't worry. The stock still has a lot of upside left.

Open Text (OTEX)

Known as one of the world's leading data management firms for large organizations, Open Text ranks as the biggest software company in Canada. A roster of A-list clients helps a great deal. Some of Open Text's stable of blue-chip clients include Coca-Cola, BP, and Visa.

In January, the company completed the acquisition of GXS Group, which provides corporate cloud services, and added such marquee clients as Bank of America, FedEx, and General Electric.

The company has a market cap of $5.95 billion, operating margins of more than 17%, and a forward PE of 13.91—about a 15% discount from the overall market.

The stock also has two new catalysts; in January, the firm reported earnings that beat the consensus of analysts and it announced a 2-for-1 stock split.

Smart Technologies (SMT)

Smart Technologies is a company that literally lives up to its name. It's a supplier of interactive education tools, used by more than 40 million students, in more than 175 countries.

As such, it has a rich legacy in this sector. In 1991, the company developed the first interactive whiteboard, called the SMART Board. Since then, the tech firm has made over two million of them.

Frankly, I'd like to see stronger financials. But the company is working on it. To further fatten its revenue stream, Smart Technologies is moving more deeply into the corporate e-learning market.

Smart Technologies has plenty of room to run. With a market cap of $450 million, the stock has a forward PE of 23, a roughly 20% premium to small-caps as a group.

But the PEG ratio is a different story altogether. A ratio of 1 means the stock is trading at a "fair value." But Smart Technologies has a PEG ratio of minus 2.58.

Subscribe to Money Morning here…

More from MoneyShow.com:

Internet Growth Trio

Micron: Red Hot?

Boeckl's Bets: The Long-Cycle for Tech

Monday, March 24, 2014

3 Healthcare Stocks Poised to Win Big From Obamacare

RSS Logo Susan J. Aluise Popular Posts: 4 Ways to Play the Boom in Biotech StocksCasino Stocks: 2 to Hold, 2 to FoldTesla: Should I Buy TSLA Stock? 3 Pros, 3 Cons Recent Posts: 3 Healthcare Stocks Poised to Win Big From Obamacare 4 Ways to Play the Boom in Biotech Stocks Casino Stocks: 2 to Hold, 2 to Fold View All Posts

As the clock ticks down to the Affordable Care Act's March 31 deadline, some healthcare stocks are poised to deliver gains, despite lower-than-expected enrollments in President Obama's signature health insurance exchanges.

HealthcareSurgeon185 3 Healthcare Stocks Poised to Win Big From Obamacare Source: Flickr

With less than two weeks to go until the Obamacare mandatory health insurance enrollment deadline for 2014 hits, the Department of Health and Human Services (HHS) this week said that more than 5 million people have signed up for new coverage in federal or state health insurance marketplaces so far. Although that was positive news, it's a far cry from the 7 million initial subscribers expected under the Affordable Care Act.

Health insurers, who would use the Affordable Care Act exchanges to compete for some 30 million new customers, were supposed to be big winners. But it hasn’t exactly gone according to plan. In theory, adding millions of younger, healthier individuals to the insurance pool balances the added costs of older individuals with pre-existing conditions. But in practice, 34% of uninsured Americans plan to remain so this year, according to Bankrate’s most recent Health Insurance Pulse survey.

What’s worse: HHS is eying far tougher regulations next year against health plans with narrow provider networks. That means healthcare stocks like Humana (HUM), Cigna (CI), Aetna (AET) and WellPoint (WLP), which have gained more than 50% in the past year, could face headwinds as they try to expand provider networks while keeping premiums low.

Although big insurers may retreat in the near term, here are three healthcare stocks still poised to win big from the Affordable Care Act:

Healthcare Stocks: Molina Healthcare (MOH)

Molina Healthcare 185 3 Healthcare Stocks Poised to Win Big From ObamacareMolina Healthcare (MOH) is an insurance payor focused on the Medicaid niche — it covers an estimates 2 million patients in 11 states.

MOH has a big opportunity now because the Affordable Care Act was written to expand state Medicaid programs to individuals with incomes at or below the federal poverty level — $16,000 for an individual; nearly $33,000 for a family of four. Although the Supreme Court ruled that states could opt out of expanding their Medicaid programs, 26 states and the District of Columbia have elected to expand — and other states are under pressure to reconsider.

Although Medicaid has far slimmer margins than other business lines, MOH has the expertise to gain volume as enrollees grow. It also has a strong Medicaid franchise in two key states: California and Washington. MOH has a price to earnings growth (PEG) ratio of only 0.8, suggesting that the stock could be undervalued. It also has a forward P/E of 14, lower than many other healthcare stocks.

Healthcare Stocks: Magellan Health Services (MGLN)

Magellan Health Services 185 3 Healthcare Stocks Poised to Win Big From ObamacareMagellan Health Services (MGLN) recently rebranded its business lines into three distinct units. The company’s behavior health affiliates, along with integrated health business Magellan Complete Care, are branded under the Magellan Healthcare business. Magellan Rx Management focuses on Magellan’s pharmacy business. And the specialty solutions business is now branded under NIA Magellan.

Although MGLN took a huge earnings hit in the fourth quarter of last year due to higher costs in providing care, its revenue continues to strengthen and should fare well with growth in public-sector pharmacy volume, as well as the launch of new products and services.Those new services include a particularly innovative audit tool, MRxAudit that can be used by groups to determine the effectiveness of their pharmacy benefit management services.

Another positive: Florida’s Agency for Health Care Administration chose MGLN to administer its Medicaid specialty plan for individuals with serious mental illness. The program will be implemented in eight regions throughout Florida and in 40 of its 67 counties. Right now, MGLN stock has a forward P/E of about 19 — roughly average for healthcare stocks.

Healthcare Stocks: Cerner (CERN)

cernerLogo 3 Healthcare Stocks Poised to Win Big From ObamacareWhen it comes to achieving success with the Affordable Care Act, don’t underestimate the power of information technology to help or hinder the progress. Given the disastrous technical problems that attended last fall’s launch, the heat is on all parties to ensure that the technology works as advertised.

Cerner (CERN) is a key player in the health information systems space and it could find a particularly lucrative role as a problem solver in 2014. One particular focus of innovation is electronic medical records (EMRs). According to a new report by Utah-based KLAS Research, nearly half of all large hospitals will invest in new EMR technology by 2016.

CERN’s strong focus in that niche could drive profitability — and share price — over the next two years, particularly as pressures rise to make health information systems more secure and interoperable. So far this year, CERN has gained more than 8%. The fact that CERN is trading at more than 30 times forward earnings and has a PEG ratio of 2 makes it look overvalued, compared to other healthcare stocks. However, the explosion of EMRs is likely to make CERN an attractive growth play.

As of this writing, Susan J. Aluise did not hold a position in any of the aforementioned securities. 

Sunday, March 23, 2014

Wal-Mart Stores, Inc. Announces Video Game Trade-In Service; GameStop Corp. Shares Tumble (WMT, GME)

Early on Tuesday, Wal-Mart Stores (WMT) announced that it will be starting a program that will allow customers to trade in video games and have the value applied to buying anything at Wal-Mart or Sam’s Club stores.

Wal-Mart’s new program will see the video games traded in, sent to be refurbished, and then sold through its stores. This is similar to the service that GameStop (GME) currently offers, and subsequently GME stock was substantially in pre-market trading. WMT’s new program differs from GME’s, as WMT customers will have a wider variety of products to choose from when spending the video game’s trade-in value.

Walmart U.S. chief merchandising and marketing officer Duncan Mac Naughton had the following comments about the new service: ”Gaming continues to be an important business for us and we're actively taking aim at the $2 billion pre-owned video game opportunity. When we disrupt markets and compete, our customer wins. They'll save money on video games and have the flexibility to spend it however they want.”

GameStop shares were down $1.95, or 4.91%, in pre-market trading. The company’s stock is down 19.94% YTD.

Wal-Mart shares were up 32 cents, or 0.43%, in pre-market trading. WMT stock is down 5.36% YTD.

PAY Stock: VeriFone’s Turnaround Is Actually Turning

Twitter Logo LinkedIn Logo Google Plus Logo RSS Logo Dan Burrows Popular Posts: The Top 10 S&P 500 Dividend Stocks for MarchMarijuana Stocks: A Case of Too Far, Too FastIs JCPenney This Year’s Best Buy? Recent Posts: PAY Stock: VeriFone’s Turnaround Is Actually Turning Is JCPenney This Year’s Best Buy? The Top 10 S&P 500 Dividend Stocks for March View All Posts

VeriFone (PAY) surged Wednesday on quarterly results showing that although the electronic payments processor is under assault from all sides, the market-share leader still has plenty of life left — as does PAY stock.

VerifonePromo PAY Stock: VeriFone's Turnaround Is Actually TurningThe company delivered a better-than-expected Q4 earnings report and full-year outlook this morning, and soon after the bell, PAY stock rose more than 11%. The latest figures indicate VeriFone is making progress in turning its sales around after a terrible 2013.

VeriFone has 60% of the global market share of EMV-enabled payment terminals — EMV stands for Europay, Visa (V) and MasterCard (MA) — and has wide reach on the web with VeriShield protect, among other products and services. But competition has eaten away at its business, while fast-growth mobile payments services have attracted attention from behemoths like Facebook (FB) and Google (GOOG).

VeriFone sales slumped 8.8% in 2013 to $1.7 billion, pushing the company into a full-year loss, and PAY stock has been under pressure accordingly. VeriFone stock started 2013 at about $30 a share and fell 55% in a matter of six months.

But a new management team focused on cost cuts and increased spending on research and development appears to have given VeriFone more than a fighting chance.

That has the market bullish on PAY stock. By the end of last year, VeriFone stock clawed back its losses and has been building on that ever since. Including today’s big rally, PAY is up more than 20% for the year-to-date to hit its highest level in more than a year.

VeriFone: A Good Quarter Followed by a Better Year

For the most recent quarter, VeriFone exceeded Wall Street estimates on both the top and bottom lines. Earnings per share on an adjusted basis came to 31 cents vs. a forecast of 27 cents, according to a survey by FactSet. Revenue rose almost 2% to $437 million. Analysts’ average estimate was for revenue of $429 million.

More importantly for VeriFone stock, the company’s outlook was better than analysts were modeling. For the current quarter, VeriFone expects EPS of 30 cents to 32 cents on revenue of $440 million to $445 million. The Street was forecasting 31 cents on revenue of $438 million.

PAY stock also got a lift from VeriFone’s buoyant full-year outlook. The company sees earnings coming in at $1.40 a share on revenue of $1.78 billion to $1.81 billion. Analysts, on average, were looking for EPS of $1.39 on $1.79 billion in revenue.

Although most turnarounds don’t turn, the action in VeriFone stock indicates that the market believes this one is working out. The better-than-expected quarter and outlook prompted Deutsche Bank to upgrade PAY stock to “hold” from “sell,” noting that the company appears to be growing sales once again.

Hilliard Lyons, which calls VeriFone stock a “long-term buy,” expects the company to gain momentum through the first half of 2014, and then drive higher growth rates and year-over-year growth, helped by the release of new hardware and timely product certifications.

That said, as much as PAY stock has rallied, VeriFone has a lot of work to do to make its turnaround complete. For the most recent quarter, gross margin contracted, while operating income plunged 43% year-over-year.

Operating expenses rose and will continue to do so this year as VeriFone invests more in R&D and sales and marketing. For PAY stock to retain its hard-won gains, gross margin and operating margin will have to expand, something VeriFone also targets for the second half of 2014.

Profit and revenue are on the mend and VeriFone’s balance sheet is getting healthier, but much of the second-half rebound story looks to be reflected in VeriFone stock. Barring more upgrades, PAY stock has already topped Wall Street’s average and median price targets.

Although this turnaround appears to be turning, you might want to wait for a better entry point after the post-earnings excitement calms down.

As of this writing, Dan Burrows did not hold a position in any of the aforementioned securities.

Saturday, March 22, 2014

Soaring Lime Prices Squeeze Margarita Fans, Mexican Families

Green limes on yellow tablecloth and round wooden kitchen cutting board. Flickr Open/Getty Images Lime growers in the Mexican state of Michoacan have banded together to set prices of the fruit they sell to packing companies and control supply, spurring inflation that's been above the central bank's target range for the last two months. Members of the Citrus Growers Association of Apatzingan Valley are limiting supply to guarantee a minimum price for producers, said Leonardo Santibanez, an association member and coordinator of its trade events. The policy emptied Michoacan's main citrus market of limes on March 12 after association members told farmers not to harvest their crop that day as the group pushed for a price minimum of 23 pesos per kilo (80 cents per pound), he said. The tactic has helped dry up margarita consumption in Mexico City as the fruit had become the biggest contributor to inflation nationwide, accounting for one third of last month's increase in consumer prices. The unexpected increase in lime costs may combine with new taxes on sodas and junk food that took effect Jan. 1 to pressure inflation expectations further above policy makers' target range, according to Nomura Holdings. "The shock of limes at a time when inflation is already high due to the tax reform is something we need to pay attention to," Benito Berber, a strategist at Nomura, said in an e-mail. Economists expect inflation to end the year at 4.01 percent, above the 4 percent upper limit of Banco de Mexico's target range, according to a March 6 central bank survey. Poor Quality, Higher Prices -- and Bar Customers Notice Manuel Ambrosio, a bartender at Bloo Bar in Mexico City, says he is reducing portions in the drinks he serves customers to trim his losses after limes rose. Sales of margaritas -- a popular mixed drink of fresh lime juice, tequila and salt -- have plunged 30 percent as customers complain about the poor quality of the fruit that he uses to reduce costs, he says. "These limes have no juice," the 28-year-old said, squeezing a wedge from a pile on his bar. "This is the worst I've seen prices in four years." Since December, the price of limes in Mexico City's main wholesale market has tripled to 32 pesos per kilo through mid-March. Limes, squeezed into a variety of Mexican dishes, hold the largest weighting among fruits in Mexico's inflation basket after apples. In February, lime prices nationwide surged 68 percent from the previous month, contributing 0.08 percentage point to Mexico's consumer price index, which rose 0.25 percent, according to the national statistics institute. The cost of the fruit soared 45 percent in January, pushing consumer prices up another 0.04 percentage point. The Citrus Growers Association of Apatzingan Valley "was formed so that producers can establish the price," Santibanez said in a March 12 interview in the association's offices. "For example, the association says to the distributors, 'we'll put a price of 20 pesos.' They can't go lower than that. The producers will receive 20 pesos at a minimum." Leandro Alcantar, the president of the association, wasn't available for comment. Association members have been able to push up prices after lime infestations from the state of Colima and atypical rainfall in Michoacan crimped production, making Apatzingan the producer of almost all of the fruit consumed in Mexico this year, according to Santibanez. Mexico is considering increasing lime imports to combat their high price, Economy Minister Ildefonso Guajardo said March 14. Policy May Be Illegal, Former Antitrust Commission Believes The policy may be illegal, according to Miguel Flores Bernes, a former antitrust agency commissioner and now a lawyer. "Everything points to an accord among competitors," Flores Bernes said by phone March 13. "If they are competitors, they can't agree on prices, neither a ceiling nor a floor." Santibanez denied the growers were engaging in illegal activity. He said price setting is only occurring in one step along the supply chain -- the producers' sale of limes to packing companies. The final cost to consumers remains fluid, he said. An investigation into price-fixing would only happen if a complaint is filed, Alfredo Castillo, who was appointed by President Enrique Pena Nieto to improve security and economic and social development in Michoacan, said in a March 12 interview. The Federal Economic Competition Commission, the nation's antitrust agency, declined comment. Recent violence in the state as armed vigilantes push drug cartels out of the area is also generating price speculation among producers, according to Castillo. Producers founded the Apatzingan association in 2009 for its 4,500 members in order to stop the practice of packing companies paying below-production costs, Santibanez said. The group's growers cultivate 135,000 across the Tierra Caliente valley and currently pick about 2,000 tons of the fruit per harvest day, which the association's members have limited to three days a week, he said.

Friday, March 21, 2014

Darden Restaurants, Inc. Q3 Earnings Dip; Matches Estimates; Declares Dividend (DRI)

Before the opening bell on Friday morning, Darden Restaurants (DRI) reported its third quarter earnings, posting lower overall sales compared to last year’s third quarter.

DRI’s Earnings in Brief

DRI reported third quarter sales of $2.23 billion, which were slightly below last year’s Q3 sales of $2.26 billion. Net earnings for the quarter came in at $109.7 million, down from last year’s Q3 figure of $134.5 million. The company's diluted EPS came in at 82 cents, which is significantly than last year’s Q3 EPS of $1.02. DRI met analysts’ estimates of 82 cents EPS, but came in slightly below revenue expectations of $2.26 billion. The company placed some of the blame for its lower earnings on higher direct costs and severe winter weather. Darden affirmed that diluted net EPS for FY2014 will decline between 15% and 20% compared to last year.

DRI’s Dividend

Darden declared a quarterly dividend of 55 cents, which is payable on May 5 to all shareholders on record as of April 10. The stock goes ex-dividend on April 8.

Stock Performance

DRI stock was inactive in pre-market trading. YTD, Darden stock is down 7.95%.

Thursday, March 20, 2014

Leading in a 'VUCA' world

LIS07 general george casey

Gen. Casey leaves a meeting with Iraqi army officers in Baghdad, February 2007.

(Fortune) I was recently asked to address the students of the University of North Carolina's Kenan-Flagler Business School on "Leading in a VUCA World." I must admit that as soon as I got off the call with the school's executive director, I went to the computer and Googled "VUCA." Ten seconds later it was clear why the acronym was vaguely familiar to me: It was a term coined by the U.S. Army War College in the early 1990s to describe what the world would be like after the Soviet Union's collapse: volatile, uncertain, complex, and ambiguous.

In reality, VUCA has never been more relevant, for the military and for business. I experienced VUCA environments in Bosnia (1996), in Kosovo (2000), and in Iraq (2004-07). Leading grew progressively more difficult in those conflicts, with Iraq unquestionably the toughest. I believe that my experiences leading in those environments can benefit business leaders.

The reason is that the primary function of any leader is to point the way ahead. I've learned that doing so in VUCA environments is extraordinarily difficult. Leaders need to "see around corners" -- to see something significant about the future that others don't see. Yet the more VUCA the environment, the harder it is for leaders themselves to comprehend the situation, let alone articulate a clear way forward. VUCA environments thus become invitations for inaction -- people are befuddled by the turmoil and don't act. And to succeed, you must act!

Effective action begins with a clear statement of what needs to be accomplished. As the commander in Iraq and later as the Army Chief of Staff, I made the No. 1 question I asked: "What are we really trying to accomplish?" The higher in the organization I was, the more complex the issues became and the harder it was for me to answer that question clearly and succinctly. I had to force myself to get clarity in my own mind so that I could clearly articulate to my subordinates how I saw things and what I wanted them to do. I found that the clearer I could be -- even if I wasn't exactly right -- the better we executed. Without a clear focus, there was no common purpose, and without common purpose, there wasn't effective execution. In war -- and business -- that is fatal.

MORE: The World's 50 Greatest Leaders

Consider my experience in Iraq. When I took command in July 2004, I had about 30 days to come to grips with the new environment, build a relationship with the new Iraqi government, and develop a plan for succeeding, all the while keeping a burgeoning insurgency at bay. I had a lot on my plate.

Then, almost immediately, we confronted a countrywide uprising after a young Marine made a wrong turn and drove too close to a militia leader's house in the key city of Najaf, home to the Imam Ali Mosque, the third-holiest site in Shia Islam. In response the militia leader, Muqtada al-Sadr, whose forces had been terrorizing the popu! lation of Najaf for months, rapidly mobilized his forces in Najaf, Baghdad, and southern Iraq, and fighting escalated. That's volatility.

With an inexperienced Iraqi government, a mere two battalions in the Iraqi army, 162,000 coalition forces from 33 countries engaged in a form of combat for which they had not prepared, in a culture they didn't fully understand or appreciate, and against a diverse and committed enemy, our ability to achieve our desired outcome was hugely uncertain. In addition, Iraq was the most complex environment I had ever experienced. I had to consider not only what the U.S. government wanted but also how our decisions would affect the Iraqi government, our coalition of 33 countries, and the varying Iraqi factions -- and that was just our side. In war the enemy has a vote. On almost every issue I had to consider multiple and competing internal and external variables that, if I chose incorrectly, could produce undesirable outcomes.

MORE: World's Greatest Leaders: 9 dynamic duos

Ambiguity? The reporting that I received was all over the map -- Sadr had been killed! No, he was just wounded. An errant bomb had damaged the mosque! No, it was the hotel next door. The Iraqi Special Forces had arrived! No, they were still on the way.

VUCA conditions conspired to postpone action. Yet I had to act fast because my troops were under attack.

Over the years I had developed an offensive mindset -- I worked aggressively and opportunistically to gain an advantage. That attitude kept me from being cowed by the complexity and ambiguity of the situation, and I was able to perform a leader's first duty -- to point a clear way ahead. I quickly saw the battle for Najaf as an opportunity for the new Iraqi government to demonstrate its strength. In less than 24 hours, I consulted with the Prime Minister and instructed my forces to restore Iraqi government control of Najaf, which in the following weeks they did. The Prime Minister had his first victory.

I! got the ! chance to apply what I had learned in Iraq when I became the Army Chief of Staff in 2007. As I began developing my vision to guide the Army through my four-year tenure, I initially thought it would be something flashy, like "America's Army -- an agile, disciplined warrior team, dominant across the spectrum of 21st-century conflict." I couldn't have been more wrong.

In a four-month tour of the Army, talking with men and women of all ranks, I found an organization stretched by six years of war and facing another five to 10 years of continual deployments. Over 3,000 soldiers had given their lives, leaving 10,000 surviving family members. Another 25,000 soldiers had been wounded, some 5,000 seriously enough to require long-term care. We also were just beginning to come to grips with the impacts of posttraumatic stress and traumatic brain injury on thousands of soldiers. In all the turbulence, readiness suffered. The magnificent volunteer force that we had built so painstakingly since the early 1970s was seriously frayed.

MORE: 20 of Hollywood's greatest fictional leaders

I came to see the Army as out of balance -- so weighed down by current demands that we couldn't adequately care for soldiers or prepare for the future. I realized that when you are out of balance, there is only one thing to do: Get back in balance. I thus arrived at a simple -- and clear -- vision statement: "Put the Army Back in Balance." It wasn't quite so glamorous a vision as I had originally imagined, but because it was clear, it guided a Herculean Army-wide effort that left us in a fundamentally different and better position four years later.

Leaders are human and possess only so much intellectual and emotional energy. To succeed in a VUCA world, we must expend that energy in the areas that produce the highest payoff for our organizations. Our first priority must be developing and articulating a clear vision to drive our organizations' actions. The clearer leaders can be about what they want to acco! mplish, t! he better their organizations will execute in the volatility, uncertainty, complexity, and ambiguity of today's global business environment.

George W. Casey Jr. was Army Chief of Staff and Commanding General of the Multinational Force in Iraq. He is now a consultant with the Minot Group and a Distinguished Senior Lecturer of Leadership at Cornell.

This story is from the April 7, 2014 issue of Fortune. To top of page

Wednesday, March 19, 2014

One Sure Way To Tell If Your Aging Parent Shouldn't Be Driving

Living in a county with a large aging population, I frequently see news reports about accidents and tragedies involving elderly drivers.  In recent cases, older drivers have crashed into plate glass storefronts, hit pedestrians, driven into a body of water and even disappeared altogether when night driving.  Maybe family had told them or asked them to stop without success.

The struggle to get an aging parent to give up driving can be very difficult for family members, particularly when the aging person thinks he or she is perfectly fine.  Loss of independence is a very threatening thing for most people.  An aging parent who is determined to keep driving, despite warning signs that it's time to give up the keys might not be willing to listen to family members.  But, the elder might be persuaded to get a driving evaluation by an objective person just to "prove I'm fine".

The Burke Institute http://www.burke.org/outpatient/services/occupational-therapy in White Plains, N.Y.  offers what looks to me like a model program for drivers who may be marginal.  It's their Driver Evaluation Program, conducted by licensed occupational therapists.

older man driverThe program is described on their website as  evaluating "vision, perception, attention, reaction time, memory, judgment, safety awareness and cognition. Each is thoroughly assessed to determine if the patient can continue to drive safely for themselves and those around them.  The in-vehicle evaluation, performed by participating certified driving instructors, allows a third party professional to assess how all areas come together during the actual task of driving. This comprehensive testing enables professionals to make a reliable recommendation based on medical knowledge."

I have long been an advocate of using licensed occupational therapists to do the job of assessing the multiple skills involved in aging parents' driving, rather than relying only on family's opinions when there is a conflict with the elder.  This is the first program I've seen that is conducted in a rehabilitation facility by a group of professional occupational therapists.  It lends an air of credibility to the concept of assessment and could make it easier to get the elder there for evaluation. A doctor's prescription is required.  That also takes the onus off the doctor, who may be reluctant to say that an aging patient should stop driving when the doctor and patient have had a long relationship and the doctor has never witnessed the elder's driving.  There may be signs of early dementia in the elder, but everyone, including the doctor, is hesitant to say that the elder should stop driving now.

As a retired personal injury attorney who represented victims of auto accidents, some caused by these aging drivers who should have given up the keys before they hurt my clients, I can only applaud the Burke Institute for its program.  I would like to see programs like it all over the country, using their method as a model.  Getting this kind of testing is one sure way to tell if your aging parent should give up the car keys for good.

The cost of the program is $268, including a one-hour evaluation (ability testing), with recommendations and a report that is sent to the driver or physician requesting the evaluation.  With a report describing driving impairments in hand, it would be easier for any physician to tell an aging client it's time to stop driving.  If the elder gave permission to the family to receive the information, all involved could plan for alternative transportation arrangements to maintain the elder's activities.  And the cost of this testing is far lower than the price a dangerous driver hurting someone or even damaging a car.

From what I've observed with aging individuals, however, the biggest challenge for families may not be finding an occupational therapist to do such an evaluation of driving ability. It will be getting the elder to go for evaluation.  Perhaps those who need it most will protest the loudest and refuse to be tested. It may be up to responsible family members to use other means of persuasion.

Until next time,
Carolyn Rosenblatt
AgingParents.com

Top Shipping Stocks To Own For 2014

Netflix (NASDAQ: NFLX  ) has traditionally been a notable target among short-sellers. Even if the bears have been running for cover lately, the stock still carries a relatively high short interest ratio of around 10%. But shorting Netflix has been a losing proposition over the last years, and the way things are going, it could also be a very expensive mistake on a forward-looking basis.

Competitive strengths
One of the most popular arguments among Netflix short-sellers is that the company lacks the competitive strengths to succeed in the long term. Amazon.com (NASDAQ: AMZN  ) is usually seen as the most challenging competitor for Netflix over the coming years.

Amazon Prime offers free two-day shipping, access to the Kindle Owners' Lending Library, and more than 40,000 tittles available for streaming via its Prime Instant online video service for a conveniently low price of $79 per year. The service now has "tens of millions" of members, according to the company, and it gained more than 1 million new members in the third week of December alone, so it continues growing at full speed.

Top Shipping Stocks To Own For 2014: CirTran Corp (CIRC)

CirTran Corporation, incorporated on March 23, 1987, manufactures, markets, and distributes internationally an energy drink under a license with Playboy Enterprises, Inc. (Playboy) through its subsidiary, CirTran Beverage Corporation. It operates in Beverage Distribution and Contract Manufacturing segments. In the United States, it provides a mix of high- and medium-volume turnkey manufacturing services and products using various high-tech applications for electronics original equipment manufacturers (OEMs) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries. The Company�� services include pre-manufacturing, manufacturing, and post-manufacturing services.

Beverage Distribution

CirTran Beverage Corporation (CirTran Beverage) manufactures, markets, and distributes Playboy-licensed energy drinks, flavored water beverages, and related merchandise through various distribution channels. As of December 31, 2012, the Company had 65 countries throughout Europe, Africa, Australia, the Pacific, and the Middle East.

Contract Marketing

CirTran Products Corp. pursues contract-manufacturing relationships in the domestic consumer products markets, including products in areas, such as home/garden, kitchen, health/beauty, toys, licensed merchandise, and apparel for film, television, sports, and other entertainment properties. The Company concentrates its product development efforts into three areas: home and kitchen appliances, beauty products, and licensed merchandise. Through CirTran - Asia, Inc., the Company designs, manufactures, and supplies products in the international electronics, consumer products, and general merchandise industries for various marketers, distributors, and retailers selling overseas. This subsidiary provides manufacturing services to the direct-response and retail consumer markets.

The Company competes with Hansen�! � Energy, Diet Red, Monster Energy, Lost Energy, Joker Mad Energy, Ace Energy, Unbound Energy, Rumba energy juice, Red Bull, Rockstar, Full Throttle, No Fear, Amp, Adrenaline Rush, 180, Extreme Energy Shot, Red Devil, Rip It, NOS, Boo Koo, and Vitaminenergy.

Advisors' Opinion:
  • [By CRWE]

    Last Friday, CIRC remained (0.00%) +0.000 at $.0005 at the close (ref. google finance August 30, 2013 ��Close).

    CirTran Corporation has recently filed its Quarterly Report on Form 10-Q for the period ended June 30, 2013, showing continued growth in sales and a dramatic improvement in profits. CirTran�� sales were again driven by its Playboy Energy Drink line, which has grown to represent nearly 98% of revenues.

    For the quarter, CirTran previously reported sales of $1,096,691, a 247% increase over the $315,755 reported for the same period a year ago. For the six months ended June 30, 2013, CirTran reported sales of 1,964,843, a 110% improvement over the $934,455 reported for the first half of 2012.

Top Shipping Stocks To Own For 2014: Monster Beverage Corp (MNST)

Monster Beverage Corporation, formerly Hansen Natural Corporation, incorporated on April 25, 1990,is a holding company. The Company develops, markets, sells and distributes alternative beverage. The alternative beverage category combines non-carbonated ready-to-drink iced teas, lemonades, juice cocktails, single-serve juices and fruit beverages, ready-to-drink dairy and coffee drinks, energy drinks, sports drinks, and single-serve still water (flavored, unflavored and enhanced) with new age beverages, including sodas that are considered natural, sparkling juices and flavored sparkling beverages. It has two reportable segments, namely Direct Store Delivery (DSD), whose principal products comprise energy drinks, and Warehouse (Warehouse), whose principal products comprise juice-based and soda beverages. The DSD segment develops, markets and sells products primarily through an exclusive distributor network, whereas the Warehouse segment develops, markets and sells products primarily directly to retailers. Corporate and unallocated amounts that do not relate to the DSD or Warehouse segments specifically, have been allocated to Corporate and Unallocated.

During the year ended December 31, 2012, it continued to expand its existing product lines and flavors and further develop its distribution markets. In particular, it continued to focus on developing and marketing beverages that fall within the category generally described as the alternative beverage category. During the year ended December 31, 2012, it introduced a number of new products, including Monster Rehab Tea + Orangeade + Energy, a non-carbonated energy drink with electrolytes, Monster Energy Zero Ultra, a carbonated energy drink which contains zero calories and zero sugar, bermonster Energy Brew, a non-alcoholic energy drink, manufactured using a brewed fermentation process, Hansen�� Coconut Water, in original and tropical flavors, packaged in re-sealable Tetra Prisma boxes, Peace Tea Cranberry, Pink Lemonade and Texas-Style Sweet ! Tea, ready-to-drink iced teas, Monster Cuba-Lima, a carbonated lime flavored non-alcoholic energy drink, Monster Energy Dub Edition Baller�� Blend, a carbonated punch + energy drink and Monster Energy Dub Edition Mad Dog, a carbonated punch + energy drink.

DSD Segment

Monster Energy Drinks offers products under the Monster Energy drink product line: Monster Energy, Lo-Carb Monster Energy, Monster Energy Assault, Monster Khaos, Monster M-80 (named Ripper in certain countries), Monster MIXXD, Monster Energy Absolutely Zero, Monster Energy Import and Import Light, Monster Energy Dub Edition Baller�� Blend, Monster Energy Dub Edition Mad Dog, M3 Monster Energy Super Concentrate energy drinks, bermonster Energy Brew, Monster Energy Zero Ultra and Monster Cuba-Lima.

Java Monster Coffee + Energy Drinks - A line of non-carbonated dairy based coffee + energy drinks. It offers products under the Java Monster product line: Java Monster Kona Blend, Java Monster Loca Moca, Java Monster Mean Bean, Java Monster Vanilla Light, Java Monster Irish Blend and Java Monster Toffee. Monster Energy Extra Strength Nitrous Technology Energy Drinks - A line of carbonated energy drinks containing nitrous oxide. It offer products under the Monster Energy Extra Strength Nitrous Technology product line: Super Dry, Anti Gravity and Black Ice.

-Presso Monster Coffee + Energy Drinks - A line of non-carbonated dairy based coffee + energy drinks. It offers products under the X-Presso Monster coffee + energy drinks product line: X-Presso Monster Hammer and X-Presso Monster Midnite.

Monster Rehab Tea + Energy Drinks - A line of non-carbonated energy drinks with electrolytes. It offers products under the Monster Rehab drink line: Monster Rehab Tea + Lemonade + Energy, Monster Rehab Rojo Tea + Energy, Monster Rehab Green Tea + Energy, Monster Rehab Protean + Energy and Monster Rehab Tea + Orangeade + Energy.

Worx Energy Energy Shots - A line of energy suppleme! nts which! contains zero calories and zero sugar. It offers products under the Worx Energy energy shot product line: Original Formula and Extra Strength.

Peace Tea Iced Teas - A line of ready-to-drink iced teas. It offers products under the Peace Tea product line: green tea, imported Ceylon tea, sweet lemon tea, razzleberry tea, cranberry tea, pink lemonade tea, Texas-style sweet tea and Caddy Shack tea + lemonade.

Warehouse Segment

Hansen�� brand sodas have been a natural soda brand on the West Coast of the United States for more than 30 years and are made with natural flavors. Hansen�� brand sodas, sweetened with cane sugar, and Hansen�� Diet Sodas, sweetened with Splenda no calorie sweetener and Acesulfame-K, contain no preservatives, sodium, caffeine or artificial colorings. It offers sodas under the Hansen�� brand name: Hansen�� Sodas, Hansen�� Diet Sodas and Hansen�� Natural Mixers, as well as Hansen�� Sparkling Waters, in a variety of flavors.

Its Blue Sky products contain no preservatives, artificial sweeteners, caffeine (other than its Blue Sky energy drinks) or artificial coloring and are made with sugar and natural flavors. It offers products under the Blue Sky product line: Blue Sky Natural Soda, Blue Sky Zero Calorie Sodas (sweetened with Truvia brand stevia extract, an all natural sweetener), Blue Sky Premium Sodas, Blue Sky Organic Natural Sodas, Blue Sky Seltzer Waters, Blue Sky Blue Energy drinks, Blue Sky Zero Calorie Blue Energy drinks, Blue Sky Caf Energy drinks and Blue Sky Recover Energy drinks.

Its original Hansen�� energy drinks compete in the functional beverage category, namely, beverages that provide a benefit in addition to simply delivering refreshment. It offers products under the Hansen�� energy drink product line: Hansen�� Natural Energy Pro, Hansen�� Energy Diet Red and Hansen�� Natural Stamina Pro.

Its fruit juice product line includes Hansen�� Natural Apple Juice, Ha! nsen�� ! Natural Grape Juice, White Grape Juice, Pineapple Juice, Apple Grape Juice, Apple Strawberry Juice, Orange Juice, Cranberry Juice, Cranberry-Apple Juice, Cranberry-Grape Juice, Ruby Red Grapefruit Juice, and Organic Apple Juice. In March 2012, it added Hansen�� Natural Apple Orange Pineapple Juice which contains 100% juice as well as 120% of the United States Recommended Daily Allowances (the USRDA) for vitamin C. It also offer Hansen�� Natural Lo-Cal juice cocktails, a line of all natural, low-calorie cocktails in four flavors. The Lo-Cal juice cocktails are sweetened with Truvia sweetener. Hansen�� juice products compete in the shelf-stable juice category.

It offers a number of aseptically packed boxed juice products, including its dual-branded multi-vitamin 100% juice line, which itsell in conjunction with Costco Wholesale Corporation (Costco) through Costco stores. It offers its Hansen�� Natural line of multi-vitamin 100% juices to other customers. These multi-vitamin juices contain eleven essential vitamins and six essential minerals and are available in a variety of flavors. In February 2012, it added Hansen�� Natural Organic Apple Juice, a 100% USDA Certified Organic Apple Juice with 100% of the USRDA for vitamin C.

Its Hansen�� Junior Juice product line is a 100% juice line targeted at toddlers and preschoolers. These juices have added calcium and all flavors contain 100% of the daily recommended allowance of vitamin C. It also offers organic juices as well as Hansen�� Organic Junior Water, a lightly flavored reduced calorie beverage, both of which contain 100% of the daily recommended allowance of vitamin C. In addition, it offers Junior Juice Coconut Water Twist, a line of fruit and coconut water juices containing 100% of the daily recommended allowance of vitamin C.

Its Hubert�� Lemonade is a line of premium ready-to-drink lemonades. Hubert�� Lemonade is sweetened with cane sugar and Truvia sweetener. Hubert�� Lemonade i! s all nat! ural and contains no preservatives, artificial sweeteners, caffeine, or artificial colorings. It offers products under the Hubert�� Lemonade product line: Strawberry Lemonade, Limeade, Mango Lemonade, Honey Lemonade, Raspberry Lemonade and Original Lemonade. It added Cherry Limeade and Blackberry Lemonade flavors to the product line in February 2012 and October 2012, respectively. In July 2012, it introduced 4-count multi-packs of select flavors.

Hubert�� Half & Half is sweetened with cane sugar and Truvia sweetener, and contains no preservatives, artificial sweeteners, or artificial colorings. Its Fruit and Tea Stix product line is an all-natural, low-calorie powder drink mix line, sweetened naturally with Truvia sweetener. Its Angeleno Aguas Frescas is a line of premium ready-to-drink aguas frescas. Angeleno Aguas Frescas are sweetened with cane sugar and real fruit juice and contain no preservatives, artificial sweeteners, caffeine, or artificial colorings. It offers flavors under the Angeleno Aguas Frescas product line: Mango, Melon, Pineapple, Jamaica (Hibiscus) and Tamarindo. Its Hansen�� Natural PRE products include a line of prebiotic and probiotic digestive wellness ready-to-drink beverages and powder drink mixes, containing specially formulated blends by Jarrow Formulas. PRE prebiotic ready-to-drink beverages are sweetened with either cane sugar or stevia. PRE probiotic powder drink mixes are sweetened with cane sugar and stevia. In March 2012, it introduced Hansen�� Natural Coconut Water, a line of premium 100% Coconut Waters available in Pure and Tropical flavors.

The Company competes with TCCC, PepsiCo, Inc. (PepsiCo), The Dr. Pepper Snapple Group, Inc. (the DPS Group), Red Bull Gmbh, Kraft Foods, Inc., GlaxoSmithKline plc, Nestle Beverage Company, Tree Top Inc. (Tree Top), Ocean Spray Cranberries Inc. (Ocean Spray), Red Bull, Rockstar, Full Throttle, No Fear, Amp, Adrenaline Rush, NOS, Venom, Redline, 180, Red Devil, Rip It, Xenergy, 5-Hour Energy ! Shots, Mi! O Energy, Stacker 2, VPX Redline Energy Shots, Red Bull, Rockstar, Burn, V-Energy, Lucozade, Adrenaline Rush, Power Play, Mother, Hell, Shock, Tiger, Boost, Gladiator, TNT, Shark, Hot 6, Nalu, Battery, Bullit, Flash Up, Black, Non-Stop, Bomba, Semtex, Starbucks Frappuccino, Starbucks Double Shot, Starbucks Double Shot Energy Plus Coffee , other Starbucks coffee drinks, Rockstar Roasted, Seattle�� Best, illy issimo coffee, Full Throttle Coffee, Arizona, Lipton, Snapple, Nestea, Xing Tea, Honest Tea, Gold Peak Tea, Fuze Tea, the DPS Group, Cott Corporation and National Beverage Corporation, Jones Soda Co., Crystal Geyser, J.M. Smucker Company, Reeds, Inc., Zevia, Tree Top, Mott��, Martinelli��, Welch��, Ocean Spray, Tropicana, Minute Maid, Langers, Apple , Eve, Seneca, Northland, Juicy Juice, Old Orchard, Calypso, Simply Lemonade, Minute Maid, Cabana, Tropicana, Newman�� Own, Vita Coco, ZICO and O.N.E.

Advisors' Opinion:
  • [By Rich Bieglmeier]

    Monster Beverage Corporation (MNST) results for its third quarter ended September 30, 2013 will be released on Thursday, November 7, 2013 after the close of the market. The company also said that chairman and chief executive officer Rodney Sacks and vice chairman and president Hilton Schlosberg will host an investor conference call that same day at 2:00 p.m. Pacific Time to review the company's financial results and operations.

  • [By John Divine]

    "Alternative beverage" and energy drinks company Monster Beverage (NASDAQ: MNST  ) logged some of the steepest losses in the index today, losing 3.6%. There wasn't much material news today for investors to be fearful of, but the same can't be said for the last several months. One perpetual setback for the company is the legal risk it assumes for selling and marketing its controversial energy drinks. In May, for example, the city of San Francisco sued Monster for marketing its caffeine-heavy drinks to kids without concern for potential health risks.�

Best Income Stocks To Invest In 2014: Volcano Corporation(VOLC)

Volcano Corporation designs, develops, manufactures, and commercializes intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products used in the diagnosis and treatment of vascular and structural heart disease. It offers multi-modality consoles, which are marketed as stand-alone units that can be integrated into hospital-based interventional surgical suites, such as catheterization laboratories. The company provides IVUS products, including single-procedure disposable phased array and rotational IVUS imaging catheters; and additional functionality options comprising virtual histology tissue characterization, and ChromaFlo stent apposition analysis. It also offers FFR products, such as pressure and flow consoles, and single-procedure disposable pressure and flow guide wires used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque?s physiological impact on blood flow and pressure. In addition, the com pany develops and manufactures optical monitors for the telecommunication industry; laser and non-laser light sources; optical engines used in the medical OCT imaging systems and advanced photonic components; and sub-systems used in spectroscopy and other industrial applications. Its products under development include image-guided therapy device and micro and thrombectomy catheters. The company?s ongoing clinical studies comprise assessment of dual anti-platelet therapy with drug-eluting stents; vascular evaluation for revascularization; fractional flow reserve and intravascular ultrasound relationship study; adensonine vasodilation independent stenosis evaluation; and evaluation of XIENCE PRIME. It sells its products through direct sales force and distributors, as well as through third parties supply and distribution agreements primarily in the United States, Japan, Europe, the Middle East, Africa, and internationally. The company was founded in 2000 and is headquartered i n San Diego, California.

Advisors' Opinion:
  • [By Monica Gerson]

    Volcano (NASDAQ: VOLC) shares dropped 15.89% to $20.49 in pre-market trading after the company reported Q3 revenue. JP Morgan downgraded the stock from Overweight to Neutral and lowered the price target from $29.00 to $24.00.

  • [By Teresa Rivas]

    Shares of Volcano (VOLC) were up 8% in afternoon trading, following the company�� better-than-expected second-quarter earnings report and a spate of positive analyst commentary.

    The medical device company said it earned 3 cents a share, whereas analysts were expecting a one cent per share loss. Revenues of $101.3 million also topped consensus estimates of $97.9 million.

    Volcano also issued mixed guidance for the full year, saying it expects to earn between 3 and 5 cents a share on revenue of $394 million to $400 million. Analysts are modeling for earnings per share of a nickel on $395.8 million in sales.

    Analysts were also largely positive about the quarter. Canaccord Genuity�� Jason Mills and Jeffery Chu upgraded the stock from Hold to Buy and boosted their price target by $5 to $26 on the news. ��olid or improving revenue growth trends and margin expansion are tried and true drivers of small-cap med-tech multiples. However, since October 2010, VOLC has lost over 20% of its value amid declining growth (admittedly from a high level) and inconsistent gross margin performance, which drove multiple contraction to its current discount relative to the broad comp group. However, improving trends in the core IVUS business, easing Y/Y comps, strong margin expansion potential via manufacturing transition to Costa Rica in 2014, and several catalysts on the horizon (e.g., new products, clinical data), portend a more favorable risk/reward profile in the stock at current trading levels.��/p>

    Raymond James analyst Jayson Bedford reiterated an Outperform rating on the stock and boosted his target price by $1 to $25. �� re-acceleration to double-digit constant currency growth and guidance that was maintained should help improve investor sentiment. At 2.5x EV/Sales, we do not believe investors are giving Volcano credit for its 9-11% top-line growth profile, with visibility into 70% gross margins. Additionally, we expect investor enthusiasm to inc

  • [By Ben Levisohn]

    Strategist Andrew Garthwaite and team explain why companies like Sprint (S),� American Water Works (AWK), Volcano (VOLC), Southern (SO) and Level 3 Communications�(LVLT) could get hit by the taper:

  • [By Ben Levisohn]

    Instead of an eruption, Volcano (VOLC) got an earnings-induced collapse instead.

    Associated Press

    Medical-device maker Volcano said its third quarter profit would miss Wall Street forecasts, and 2013 sales would also disappoint. And 2014? Well, that didn’t look too exciting other.

    JPMOrgan analyst Christopher Pasquale and team have had enough:

    We are downgrading VOLC shares to Neutral from Overweight following the company�� negative 3Q preannouncement and disappointing initial 2014 growth outlook Monday after the close. While we continue to see significant long-term potential for Volcano�� technologies, we are concerned by persistent headwinds to its core IVUS franchise and slowing FFR growth. With our conviction in a pipeline-driven reacceleration reduced and visibility into meaningful new growth drivers unlikely for several quarters, we are moving to the sidelines.

    Canaccord Genuity’s Jason Mills and Jeffrey Chu also cut Volcano to Hold–just a quarter after upgrading it–and even today’s drop might not make it worth buying. They explain why:

    Our upgrade of VOLC last quarter was predicated on the improving trends in the core IVUS business, FFR continuing as a long-term growth engine, and the potential material gross margin expansion. While Q3 results included pockets of good news, adverse trends predominated.
    While US IVUS rebounded modestly, driven by peripheral IVUS (+40% Y/Y), IVUS and FM results in Japan were very disconcerting to us (-19%, +8%, respectively), and portend share loss, in our estimation. Also, while we still expect significant gross margin expansion long term, it seems we may have to wait longer than expected.

    In sum, we would not aggressively buy weakness unless the stock is over-penalized on these results – i.e. below $20.

    While shares of Volcano have dropped 15% to $20.74, large-cap medical device companies are having a solid day. Boston Scienti

Top Shipping Stocks To Own For 2014: Select Sector Financial Select Sector SPDR Fund (XLF)

Financial Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Financial Select Sector of the S&P 500 Index (the Index). The Index includes financial service firms with diversified business lines ranging from investment management to commercial and investment banking.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:
  • [By Ben Levisohn]

    The�Consumer Discretionary Select Sector SPDR�(XLY) has dropped 1.1% to $60.39, while the�Financial Select Sector SPDR(XLF) is off 0.9% at $20.23.� Hardest hit is the�Utilities Select Sector SPDR (XLU), which has dropped 1.6% to $37.32, while the Industrial Select Sector SPDR ETF (XLI) has fallen 1% to $46.49. The�Technology Select Sector SPDR (XLK) is the top performer: It�� down 0.5% at $32.39.

  • [By Holly LaFon]

    As the financial sector began to heal in 2012, it was reflected in the price of stocks ��the Financial Select Sector SPDR (XLF) increased 31% over the past year, more than doubling from its 2009 lows. It also catapulted Berkowitz�� fund to the top-performing percentile of mutual funds this year.

  • [By Ben Levisohn]

    Shares of Bank of America have fallen 1.8% to $14.34 today, while JPMorgan Chase (JPM), which is facing a mortgage probe of its own, has dropped 2% to $53.07. Citigroup (C) has declined 2.2% to $50.48, while Goldman Sachs (GS) is off 1.8% at 160.44. The Financial Select Sector SPDR ETF (XLF) has fallen 1.7% to $20.02 today.

Top Shipping Stocks To Own For 2014: Usinas Siderurgicas de Minas Gerais SA Usiminas (USIM3)

Usinas Siderurgicas de Minas Gerais SA Usiminas, formerly COSIPA - Companhia Siderurgica Paulista, is a Brazil-based company engaged in the steel industry. The Company is principally involved in the production and sale of flat rolled steel. The Company and its subsidiaries operate throughout the steel production process. The Company divides its business into four segments: Mining; Solutions Usiminas and Automotive Usiminas, both units are related to steel processing and unit of capital goods and services through Usiminas Mechanics. The Company provides its products to various industrial sectors, such as automotive, marine, oil and gas, construction, machinery and equipment, among others. The Company offers its services both in Brazil and abroad. On December 20, 2013, the Company concluded transfer of the total stake in the share capital of Automotiva Usiminas SA to Aethra Sistemas Automotivos SA. Advisors' Opinion:
  • [By Ney Hayashi]

    The Ibovespa rebounded from its biggest two-day drop since July 2012 as Usinas Siderurgicas de Minas Gerais SA (USIM3) led steelmakers higher, following a rally in commodity prices.

Top Shipping Stocks To Own For 2014: Shire PLC (SHPG)

Shire plc (Shire), incorporated on January 28, 2008, is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. As of December 31, 2012, the Company�� products included VYVANSE/VENVANSE (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), FOSRENOL (lanthanum carbonate), XAGRID (anagrelide hydrochloride), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant) and DERMAGRAFT(Human Fibroblast-Derived Dermal Substitute). As of December 31, 2012, the Company�� products under development included INTUNIV (extended release guanfacine), VYVANSE/VENVANSE (lisdexamfetamine dimesylate), INTUNIV, Guanfacine Carrier Wave, LIALDA (mesalamine)/MEZAVANT (mesalazine), RESOLOR (prucalopride), RESOLOR (prucalopride), SPD 557(M0003), XAGRID, VYVANSE (lisdexamfetamine dimesylate), REPLAGAL (agalsidase alfa), HGT-4510, HGT-2310, HGT-1410, HGT-1110, HGT-3010, and DERMAGRAFT. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.

VANSE/ VENVANSE

VYVANSE is a New Chemical Entity (NCE) and is the pro-drug stimulant for the treatment of ADHD, where the amino acid l-lysine is linked to d-amphetamine. VYVANSE is therapeutically inactive until metabolized in the body. The United Stat! es Food and Drug Administration approved VYVANSE as a once-daily treatment for children aged 6 to 12 with ADHD in February 2007, for adults in April 2008 and for adolescents aged 13 to 17 in November 2010. VYVANSE is available in the United States in six dosage strengths: 20 milligram, 30 milligram, 40 milligram, 50 milligram, 60 milligram and 70 milligram. Health Canada approved VYVANSE for the treatment of ADHD in pediatric patients aged 6 to 12 in February 2009, and for adolescents and adults in November 2010. In April 2012, ANVISA, the Brazilian health authority, granted marketing authorization approval for lisdexamfetamine dimesylate for the treatment of ADHD in children aged 6-12.

ADDERALL XR

ADDERALL XR is an extended release treatment for ADHD, which uses MICROTROL drug delivery technology and is designed to provide once-daily dosing. It is available in 5 milligram, 10 milligram, 15 milligram, 20 milligram, 25 milligram and 30 milligram capsules and can be administered either as a capsule or sprinkled on soft food. The United States Food and Drug Administration has approved ADDERALL XR as a once-daily treatment for children aged 6 to 12 with ADHD, for adults in and for adolescents aged 13 to 17. Teva Pharmaceutical Industries, Ltd. (Teva) and Impax Laboratories, Inc. (Impax) commenced commercial shipment of their authorized generic versions of ADDERALL XR in April and October 2009, respectively. Shire receives royalties from Impax�� sales of authorized generic ADDERALL XR.

INTUNIV

INTUNIV is a selective alpha-2A receptor agonist indicated for the treatment of ADHD. Alpha-2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signalling in the prefrontal cortex (Cell. 2007; 129:397-410). INTUNIV is non-scheduled and has no known potential for abuse or dependence. The United States Food and Drug Administration approved INTUNIV in September 2009, as a once-daily monotherapy treatment of ADHD in children and adolesce! nts aged ! 6 to 17. It is available in 1 milligram, 2 milligram, 3 milligram and 4 milligram tablets.

EQUASYM

Shire has acquired from UCB the worldwide rights (excluding the United States, Canada and Barbados) to EQUASYM (methylphenidate hydrochloride) IR and XL for the treatment of ADHD in children and adolescents aged 6 to 18. At December 31, 2012,EQUASYM XL was commercially available in 10 countries in 10mg, 20mg and 30mg strengths. EQUASYM XL is marketed in Mexico and South Korea under the trade name METADATE CD.

LIALDA/MEZAVANT

LIALDA is indicated for the induction ofmild to moderately active UC and for the maintenance of remission of UC. The addition of the indication for maintenance of remission of ulcerative colitis was approved by Health Canada in February 2011, and by the United States Food and Drug Administration in July 2011. LIALDA is once-daily oral formulation of mesalamine indicated for the induction and maintenance of remission. As of December 31, 2012, LIALDA/MEZAVANT (this product is marketed outside the United States as MEZAVANT) was commercially available in 19 countries either directly or through distributor arrangements.

PENTASA

PENTASA controlled release capsules are approved in the United States (marketed by Shire in the United States and by Ferring outside of the United States) and indicated for the induction of remission and for the treatment of patients with mild to moderately active ulcerative colitis. PENTASA is an ethylcellulose-coated, controlled release capsule formulation designed to release therapeutic quantities of mesalamine throughout the gastrointestinal tract. PENTASA is available in the United States in 250 milligram and 500 milligram capsules.

RESOLOR

RESOLOR (prucalopride), a 5-HT4 receptor agonists that stimulates gastrointestinal motility and acts primarily on different parts of the lower gastrointestinal tract (enterokinetic). In October 2009, RESOLOR was appr! oved by t! he EMA throughout the European Union as a once daily oral treatment for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. In July 2010, Swissmedic granted RESOLOR marketing authorization in Switzerland for the treatment of idiopathic chronic constipation in adults. RESOLOR is available in milligram and 2 milligram dose strengths, both for once-daily dosing. At December 31, 2012, RESOLOR was available in six European Union countries. Formulated as a chewable tablet, FOSRENOL is available in 500 milligram, 750 milligram and 1,000 milligram dosage strengths.

XAGRID

XAGRID (anagrelide hydrochloride) is marketed in Europe for the reduction of elevated platelet counts in at-risk ET patients. XAGRID has been granted orphan drug status in the European Union. In the United States, anagrelide hydrochloride is sold by the Company under the name AGRYLIN for the treatment of thrombocythemia secondary to a MPD.

REPLAGAL

REPLAGAL is for the treatment of Fabry disease. Fabry disease is a genetic disorder resulting from a deficiency in the activity of the lysosomal enzyme alpha-galactosidase A, which is involved in the breakdown of fats. REPLAGAL is a human alpha-galactosidase A protein made in human cells that replaces the deficient alpha-galactosidase A with an active enzyme to ameliorate certain clinical manifestations of Fabry disease. At December 31, 2012, REPLAGAL was approved in 46 countries.

ELAPRASE

ELAPRASE is a treatment for Hunter syndrome (also known as Mucopolysaccharidosis Type II or MPS II). Hunter syndrome is a genetic disorder mainly affecting males that interferes with the body's ability to break down and recycle waste substances called mucopolysaccharides, also known as glycosaminoglycans (GAGs). ELAPRASE was approved by the United States Food and Drug Administration and granted marketing authorization by the EMA for the long term treatment of patients with Hunter ! syndrome.! ELAPRASE has been granted orphan drug by both the United States Food and Drug Administration and the EMA. ELAPRASE received approval from the Ministry of Health, Labour and Welfare in Japan. At December 31, 2012, ELAPRASE was approved in 51 countries.

VPRIV

VPRIV is a treatment for Type 1 Gaucher disease. Gaucher disease is an inherited genetic disorder, which results in a deficiency of the lysosomal enzyme beta-glucocerebrosidase. VPRIV was approved by the United States Food and Drug Administration in February 2010, for the long-term treatment of patients with Type 1 Gaucher disease. The EMA approved the marketing authorization for the use of VPRIV in August 2010. VPRIV was authorized as an orphan medicine through the Centralised Procedure in Europe. At December 31, 2012, VPRIV was approved in 38 countries.

FIRAZYR

FIRAZYR is a peptide-based therapeutic developed for the symptomatic treatment of acute attacks of HAE. In July 2008 the EMA granted marketing authorization throughout the European Union for the use of FIRAZYR for the symptomatic treatment of acute attacks of HAE, and in May 2011 approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. In August 2011, the United States Food and Drug Administration granted marketing approval for FIRAZYR in the United States for treatment of acute attacks of HAE in adults aged 18 and older. After injection training, patients may self-administer FIRAZYR. FIRAZYR has been granted orphan drug by both the United States Food and Drug Administration and the EMA. At December 31, 2012, FIRAZYR was approved in 38 countries globally.

DERMAGRAFT

DERMAGRAFT is a bio-engineered skin substitute that assists in restoring damaged tissue. DERMAGRAFT is indicated for use in the treatment of full-thickness Diabetic foot ulcers (DFU) greater than six weeks in duration, which extend through the dermis, but without tendon, muscle, joint capsu! le, or bo! ne exposure. DERMAGRAFT is approved by the United States Food and Drug Administration as a Class III medical device for the treatment of DFUs. DERMAGRAFT is also approved for the treatment of DFUs in South Africa, Israel and Singapore.

The Company competes with Shionogi & Co., Ltd., Janssen-Cilag, Novartis, Medice, Eli Lilly, Warner Chilcott, Synergy Pharmaceuticals, Inc., ARYx Therapeutics, Theravance, Inc., Sucampo Pharmaceuticals, Inc., Albireo, Actelion Ltd., Protalix BioTherapeutics Inc, Genzyme, CSL Behring, Pharming Group N.V., ViroPharma, Dyax Corporation, Organogenesis, Healthpoint, Soluble System, KCI, Smith & Nephew, Aurobindo and Apotex.

Advisors' Opinion:
  • [By Alexander Maxwell]

    The market for the treatment of chronic diabetic foot ulcers has been growing and larger companies have been taking notice. Many large pharmaceutical companies have their own treatments for chronic diabetic foot ulcers. The space has also caused some major acquisitions. In 2011, Shire� (NASDAQ: SHPG  ) acquired�a drug called Dermagraft for the treatment of slow-healing diabetic foot ulcers, through its $750 million acquisition of�Advanced BioHealing. Dermagraft has been a rather lucrative product for Shire, with $153.8 million in sales�last year. As the market continues to grow, I would look for more partnerships with large pharmaceutical companies, and of course more research and development dollars being devoted toward the chronic diabetic foot ulcers indication.

  • [By John Udovich]

    Viropharma Inc. An international biopharmaceutical company, Viropharma has a pipeline focused on providing patients and physicians with new therapeutic alternatives for unmet medical needs where there are few treatment options available. In mid-September, Viropharma was soaring thanks to buyout rumors. Specifically, unnamed sources�have said that Viropharma was working with the Goldman Sachs Group Inc after attracting interest from suitors that include European drugmakers Sanofi SA (NYSE: SNY), which has been expanding into treatments of rare diseases since its 2010 acquisition of Genzyme Inc,�and Shire PLC (NASDAQ: SHPG), which develops treatments for rare illnesses such as Fabry disease. However, it should be noted that Deutsche Bank sees ViroPharma's base case valuation�at $38 per share, but the company's full value could be as high as $52 per share if the potential buyer has a Hereditary Angioedema sales force already in place. Bloomberg has since reported that the�JMP Group Inc. now says Viropharma could fetch as much as $60 a share while Akiva Felt of Oppenheimer has estimated the�company could fetch as much as $50 a share in a competitive bidding situation. On Monday, small cap Viropharma rose 0.26% to $39.26 (VPHM has a 52 week trading range of $22.12 to $40.89 a share) for a market cap of $2.57 billion plus the stock is up 76.5% since the start of the year, up 30% over the past year and up 186.1% over the past five years.

Top Shipping Stocks To Own For 2014: Petrotech Oil & Gas Inc (PTOG)

PetroTech Oil and Gas, Inc., formerly Unity Management Group, Inc., incorporated on April 10, 1998, operates and develops Enhanced Oil Recovery (EOR) opportunities within qualifying oil reservoirs in the United States using its Enhanced Oil Recovery method and technique. The company is also a construction and heavy equipment company. The Company is focussing on developing and acquisitions of technology in secondary oil recovery, oil and gas reporting software, trading software and Nitrogen and CO2 injection equipment. Enhanced oil recovery is also called improved oil recovery or tertiary recovery. The Company�� services include Work over and Installation Services, Heavy Equipment Services, Nitrogen, CO2 and Gas Mixture Treatments, Exhaust Gas Unit, Gas Assisted Gravity Drainage and Reservoir Development. During the year ended December 31, 2012, the Company acquired On Track Technology, Inc. On June 30, 2012, the Company acquired Metropolitan Computing Corp.

Work over and Installation Services

Drilling Vertical or Horizontal Well Supervision, Traditional Work over, Oilfield Work Over Rigs and Roustabout Services to be on location while recompletion, plugging or equipping of wells for in house leases and third party jobs as well. Where applicable Petrotech will utilize flexible Poly Urethane tubing for testing of wells and permanent installs for some shallow depths. The flexible tubing has a Paraffin�� and Asphalt Ines don�� stick to flexible tubing (as it does to steel tubing); and flexible tubing has an estimated 10 times longer life dependent upon the corrosiveness of production and by products, such as the water produced with hydrocarbons.

Heavy Equipment Services

Heavy Equipment Services includes heavy equipment, oilfield roustabout, crane work, water hauling, setting pumping units, separators, tanks, digging pitts and locations roads and heavy equipment services also includes highways for in house leases, third party oil companies and loca! l and government agencies.

Nitrogen, CO2 and Gas Mixture Treatments

The Company focuses in treating with Nitrogen, CO2 or a combination of the two; through two applications where applicable-Huff and Puff and Steady flooding. In cases, HoCyclic gas injection processes has been primarily restricted to the use of pure CO2 or CO2 that has been slightly contaminated.

Exhaust Gas Unit

The CO2/N2 gas mixture focuses to generated from a patented one-of-a-kind portable exhaust unit capable of producing 2.5 millions of cubic feet equivalent at 2000 psi. The exhaust unit manufacturing facility is capable of building over 100 million of daily of deliverability or 180,000 horse power of equipment per year.

Gas Assisted Gravity Drainage

Natural segregation of its gas mixture at miscibility pressure is a component in recreating a gas cap. Doubling of the primary oil recovery from a reservoir is expected with this EOR method and gas mixture. SPE paper #89357 documents GAGD recoveries averaging 63% of the OOIP.

Reservoir Development

Petrotech Oil and Gas Inc. focuses to use the technology in third dimension geophysics available, drilling and compositional reservoir modeling to devise the reservoir�� development plan. In some reservoirs has two horizontal wellbores; one each for the injection of gas and production of oil.

Advisors' Opinion:
  • [By Peter Graham]

    Last Friday, small cap marijuana stock Petrotech Oil & Gas Inc (OTCMKTS: PTOG) surged 65.7% while OSL Holdings Inc (OTCMKTS: OSLH) and WebXU Inc (OTCMKTS: WBXU) sank 20.47% and 12.02%, respectively, thanks in part to news and (in the case of two of these small caps) some paid promotions or investor relations type of activities. But will these three small cap marijuana stocks be able to sustain their highs or come out of rehab this week? Here is a reality check before you look for a quick high with them:

Top Shipping Stocks To Own For 2014: Sonoco Products Company(SON)

Sonoco Products Company provides industrial and consumer packaging products, and packaging services worldwide. It offers composite paperboard cans; paperboard packages; fiber cartridges; layered bottles and jars; laminated tubs, cups, and spools; consumer and institutional trays; and aluminum, steel, and peelable membrane easy-open closures, as well as flexible packaging, product design, tool design, fabrication, and manufacturing services. The company also produces paperboard tubes, cores, roll packaging, molded plugs, pallets, pallet components, concrete forms, rotary die boards, recycled paperboard, chipboard, tube board, lightweight corestock, boxboard, linerboard, corrugating medium, specialty grades, and recovered paper products; and steel, nailed wooden, plywood, recycled, and polyfiber reels, as well as recycles old corrugated container, paper, plastic, metal, and glass materials. In addition, it manufactures custom-printed glass covers and coasters; offers custom packing, fulfillment, and primary package filling services, as well as operates scalable service centers; contract packaging, co-packing, and fulfillment services; and temporary, semipermanent, and permanent point-of-purchase displays. Further, the company provides fabricated foam, corrugated paperboard, molded EPS and EPP, antistatic fabricated foam solutions, nesting and stacking trays, molded foam dunnage, totes and tote inserts, energy-absorbing and flotation components, and insulation components, as well as contract package testing service. Additionally, it offers insulated shippers, durable transport chests, gel packs, phase change materials, lab/pharma/diagnostic specimen transport, refrigerant materials, edge and corner protection, and temperature assurance solutions; high-visibility packaging and printed products; and blister packaging machines. The company, formerly known as Southern Novelty Company, was founded in 1899 and is based in Hartsville, South Carolina. Advisors' Opinion:

  • [By Rich Smith]

    Hartsville, S.C.-based Sonoco Products (NYSE: SON  ) is hiking prices on its signature product: cardboard.

    On Friday, Sonoco announced an across-the-board price hike on "all grades of uncoated recycled paperboard (URB) products by $40 per ton, effective with shipments in the�United States and Canada�beginning July 8, 2013." The company's Primary Materials Group, North America, Vice President Marty Pignone�explained that "the�price increase�is necessary to recover rising recovered paper and other raw materials costs."

  • [By David Fish]

    Once known as the Southern Novelty Company, Sonoco Products (SON) is a leading producer of paper-based tubes and cores, flexible packaging, rigid plastic containers, cylinder paperboard, wire and cable reels, and point-of-purchase displays.

Top Shipping Stocks To Own For 2014: Worthington Industries Inc.(WOR)

Worthington Industries, Inc. operates as a diversified metals processing company focusing on steel processing and manufactured metal products in the United States, Canada, and Europe. It processes flat-rolled steel and stainless steel for the automotive, construction, lawn and garden, hardware, furniture, office equipment, electrical control, tubing, leisure and recreation, appliance, agricultural, HVAC, container, and aerospace markets. The company also produces low-pressure liquefied petroleum gas and refrigerant gas cylinders; high-pressure and industrial/specialty gas cylinders; seamless steel high pressure cylinders for compressed natural gas storage in motor vehicles; aluminum-lined, composite-wrapped high-pressure cylinders; airbrake tanks; and consumer products. In addition, it produces recovery tanks for refrigerant gases; air reservoirs for truck and trailer original equipment manufacturers; and Balloon Time helium kits. Further, the company designs and manufactu res reusable custom platforms, racks, and pallets made of steel for supporting, protecting, and handling products throughout the shipping process; provides framing systems and stairs for mid-rise buildings, and current and past model automotive service stampings; designs, builds, and supplies light gauge steel framed commercial structures and multi-family housing units; supplies and constructs metal framing products for single family housing with a focus on military housing; and manufactures pre-engineered steel egress stair solutions. Worthington Industries was founded in 1955 and is headquartered in Columbus, Ohio.

Advisors' Opinion:
  • [By Ben Levisohn]

    Shares of Harsco have gained 4.7% to $26.43 today at 1:16 p.m., outpacing other construction & engineering companies. Dycom (DY) has advanced 0.5% to $30, KBR Inc. (KBR) has ticked up 0.1% to $33.03, Worthington Industries�(WOR) has risen 2.8% to $38.85�and Tutor Perini (TPC) has rallied 3.6% to $22.46.

  • [By Yoshiaki Nohara]

    Orix Corp., which provides leasing and loans, jumped 9.2 percent in Tokyo. Mizuno (8022) Corp. surged 18 percent after the Japanese sportswear company more than doubled its net-income forecast. Singapore Airlines Ltd. dropped 4.6 percent after posting a wider operating loss. WorleyParsons (WOR) Ltd., Australia�� largest oil and gas engineering company, plunged 13 percent after forecasting weaker earnings.

Top Shipping Stocks To Own For 2014: Ultra Petroleum Corp.(UPL)

Ultra Petroleum Corp., an independent oil and gas company, engages in the acquisition, exploration, development, production, and operation of oil and natural gas properties in the United States. It primarily focuses on developing a tight gas sand trend located in the Green River Basin of southwest Wyoming; and assessing, exploring, and developing its position in the Marcellus Shale and other horizons located in the north-central Pennsylvania area of the Appalachian Basin. As of December 31, 2011, the company owned interests in approximately 53,000 net acres in Wyoming covering approximately 190 square miles; 258,000 net acres in Pennsylvania; and 130,000 net acres in eastern Colorado?s Denver Julesburg Basin. Ultra Petroleum Corp. was founded in 1979 and is headquartered in Houston, Texas.

Advisors' Opinion:
  • [By Matt DiLallo]

    The final company that's on my list is natural gas producer Ultra Petroleum (NYSE: UPL  ) . Unlike Chesapeake and SandRidge, Ultra hasn't bet big on switching from natural gas to liquids. Instead, as a low-cost producer its focus has been on drilling profitable natural gas wells. The company made the decision to cut back on its growth plans and instead is investing within its cash flow. That strategy could make Ultra a big winner if gas prices improve further.

  • [By Aimee Duffy]

    Customer diversification and fee-based revenue are tough to beat. Let's look at some of QEP's top customers:

    Anadarko Petroleum EOG Resources (NYSE: EOG  ) Questar (NYSE: STR  ) Ultra Resources, a subsidiary of Ultra Petroleum (NYSE: UPL  )

    EOG Resources accounted for 11% of the midstream unit's revenue in 2012, while Questar accounted for 12%. Ultra is one of the two-largest shippers on QEP's Green River 60-mile crude oil pipeline (the other is Chevron).